Drugs / Dexamethasone
last change today re-read 2 minutes ago

Dexamethasone

Small molecule targets HDAC2 via activation

Developed for
plasma cell myeloma · lymphoma · diabetic macular edema · leukemia · refractory plasma cell neoplasm · cataract · acute lymphoblastic leukemia · COVID-19
+493 more · mantle cell lymphoma · macular retinal edema · non-Hodgkin lymphoma · neuropathy, painful · AL amyloidosis · autoimmune thrombocytopenia · extranodal nasal NK/T cell lymphoma · dry eye syndrome · osteoarthritis, knee · prostate cancer · Waldenstrom macroglobulinemia · lymphoblastic lymphoma · pulpitis · radiculopathy · smoldering plasma cell myeloma · retinal vein occlusion · acute respiratory distress syndrome · amyloidosis · chronic pain syndrome · diffuse large B-cell lymphoma · Hodgkins lymphoma · B-cell acute lymphoblastic leukemia · Meniere disease · non-small cell lung carcinoma · autoimmune thrombocytopenic purpura · cancer · chemotherapy-induced toxicity · cystoid macular edema · headache disorder · impacted teeth, multiple · peripheral T-cell lymphoma, not otherwise specified · plasma cell leukemia · T-cell non-Hodgkin lymphoma · acute myeloid leukemia · age-related macular degeneration · lumbar disk disease · adult acute lymphoblastic leukemia · anterior uveitis · asthma · chronic lymphocytic leukemia/small lymphocytic lymphoma · hemophagocytic syndrome · light chain deposition disease · migraine disorder · myelodysplastic syndrome · obstructive sleep apnea syndrome · osteoarthritis · osteoarthritis, hip · pneumonia · preretinal fibrosis · primary systemic amyloidosis · rotator cuff syndrome · sciatica · arthropathy · bronchiolitis · Burkitt lymphoma · choroidal neovascularization · classic Hodgkin lymphoma · keratoconus · mature T-cell and NK-cell non-Hodgkin lymphoma · metastatic malignant neoplasm in the brain · primary central nervous system lymphoma · acquired aneurysmal subarachnoid hemorrhage · ataxia telangiectasia · bronchopulmonary dysplasia · childhood acute lymphoblastic leukemia · delirium · diabetic retinopathy · glaucoma · lung cancer · MALT lymphoma · metastatic malignant neoplasm · POEMS syndrome · poisoning · precursor B-cell acute lymphoblastic leukemia · respiratory distress syndrome in premature infants · vertebral column disorder · vision disorder · acute asthma · acute leukemia · adult T-cell leukemia/lymphoma · anaplastic large cell lymphoma · B-cell childhood acute lymphoblastic leukemia · blepharitis · cataract 50 with or without glaucoma · central retinal vein occlusion · chronic conjunctivitis · colorectal cancer · conjunctivitis · epicondylitis · follicular lymphoma · glioblastoma · graft versus host disease · Graves disease · head and neck cancer · heart failure · high grade B-cell lymphoma · hypotensive disorder · kidney failure · lumbar spinal stenosis · metastatic prostate carcinoma · monoclonal gammopathy · newborn respiratory distress syndrome · nodal marginal zone B-cell lymphoma · occlusion of tributary of retinal vein · plasmacytoma · post-traumatic stress disorder · posterior uveitis · prostate adenocarcinoma · radiation-induced disorder · splenic marginal zone lymphoma · sudden hearing loss disorder · sudden sensorineural hearing loss · tinnitus · viral pneumonia · acne · acute bronchiolitis · acute conjunctivitis · acute otitis externa · acute respiratory failure · acute undifferentiated leukemia · adolescent idiopathic scoliosis · adult acute respiratory distress syndrome · allergic disease · anemia · angioimmunoblastic T-cell lymphoma · aortic valve disorder · arthritic joint disease · arthritis, sacroiliac · B-cell adult acute lymphocytic leukemia · B-cell non-Hodgkin lymphoma · B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) · bacterial conjunctivitis · blast phase chronic myelogenous leukemia, BCR-ABL1 positive · brain cancer · bullous keratopathy · CD4+/CD56+ hematodermic neoplasm · central retinal vein occlusion with macular edema · childhood onset asthma · chronic graft versus host disease · congenital adrenal hyperplasia · corneal edema · coronary artery disorder · Crohn disease · croup · cysticercosis · dengue disease · dermatitis · disease of bone structure · disease of the tendon · disease related to hematopoietic stem cell transplant · eye adnexa disorder · eye allergy · female breast carcinoma · Fuchs' endothelial dystrophy · hearing loss disorder · hematopoietic and lymphoid system neoplasm · hepatocellular carcinoma · hepatosplenic T-cell lymphoma · Hodgkin's lymphoma, lymphocytic depletion · Hodgkin's lymphoma, mixed cellularity · ileus · infertility disorder · inflammatory bowel disease · intermediate uveitis · Langerhans cell histiocytosis · Lassa fever · lichen planus, oral · lymphoid leukemia · malignant glioma · mixed phenotype acute leukemia · nervous system disorder · nodular sclerosis classical Hodgkin lymphoma · non-infectious anterior uveitis · ovarian carcinoma · pemphigus · peripheral arterial disease · pharyngitis · plasma cell neoplasm · platinum-induced ototoxicity · pleural empyema · precursor lymphoblastic lymphoma/leukemia · pregnancy disorder · primary cutaneous B-cell lymphoma · pterygium · respiratory failure · retinal detachment · shoulder impingement syndrome · sinus histiocytosis with massive lymphadenopathy · Sjogren syndrome · solitary osseous plasmacytoma · status asthmaticus · stomatitis · subjective cognitive decline · T-cell acute lymphoblastic leukemia · thrombocytopenia · tonsillitis · traumatic encephalopathy · triple-negative breast carcinoma · uveal melanoma · venous thromboembolism · wet macular degeneration · Acanthamoeba keratitis · acute apical periodontitis · acute kidney injury · acute pancreatitis · aggressive NK-cell leukemia · ALK-negative anaplastic large cell lymphoma · altitude sickness · anal fistula · anogenital human papillomavirus infection · anosmia · anterior scleritis · aphthous stomatitis · atopic eczema · atrial fibrillation · atrioventricular block · autoimmune lymphoproliferative syndrome · avascular necrosis · B-cell chronic lymphocytic leukemia · B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma · B-lymphoblastic leukemia/lymphoma with hypodiploidy · bacterial vaginosis · Bell's palsy · benign prostatic hyperplasia · benign shuddering attacks · beta thalassemia · bilineal acute myeloid leukemia · bone disorder · borderline epithelial tumor of ovary · brain edema · breast disorder · bursitis · carbon monoxide-induced delayed encephalopathy · carbon monoxide-induced parkinsonism · cardiac arrest · carpal tunnel syndrome · castration-resistant prostate carcinoma · cellulitis · central nervous system non-hodgkin lymphoma · cervical disk degenerative disorder · chemotherapy-induced oral mucositis · cholangiolocellular carcinoma · chronic obstructive pulmonary disease · chronic rhinosinusitis · cirrhosis of liver · classic congenital adrenal hyperplasia · classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency · cluster headache syndrome · Coats disease · colorectal adenocarcinoma · congenital heart block · congenital heart defects, multiple types · congenital temporomandibular joint ankylosis · congestive heart failure · corneal disorder · corneal endothelial dystrophy · Cryptococcal meningitis · cryptorchidism · depressive disorder · developmental dysplasia of the hip · discharging ear · drug-induced hearing loss · endometrioid tumor · enterocolitis · enteropathy-associated T-cell lymphoma · Epstein-Barr virus infection · esophagitis · extramedullary plasmacytoma · extramedullary soft tissue plasmacytoma · exudative vitreoretinopathy · eye disorder · female infertility · fibromyalgia · focal segmental glomerulosclerosis · frozen shoulder · gallbladder disorder · gastric neoplasm · glomerulonephritis · grade III lymphomatoid granulomatosis · Hashimoto thyroiditis · HELLP syndrome · hemangioma · hematologic disorder · hematopoietic and lymphoid cell neoplasm · hemorrhoid · hepatitis B virus infection · hernia, double inguinal · herpes simplex encephalitis · high altitude pulmonary edema · high grade malignant neoplasm · high-grade B-cell lymphoma double-hit/triple-hit · hormone-resistant prostate carcinoma · hyperbilirubinemia · hypersensitivity reaction disease · hypospadias · idiopathic multicentric Castleman disease · immune reconstitution inflammatory syndrome · infectious disease · infectious disease with sepsis · intestinal obstruction · intracerebral hemorrhage · intracranial hypotension · intrahepatic cholangiocarcinoma · intraocular lymphoma · ischemic stroke · lacrimal apparatus disorder · large-cell immunoblastic lymphoma · laryngeal disorder · leiomyoma · leptospirosis · lichen planus · light and heavy chain deposition disease · limb ischemia · liver cancer · liver disorder · liver failure · low grade glioma · lung disorder · lupus nephritis · macular degeneration · mastoiditis · meningeal tuberculosis · meningioma · metastasis from malignant tumor of colon · metastatic malignant neoplasm in the spinal cord · metastatic neoplasm · migraine with aura · migraine without aura · mixed phenotype acute leukemia, B/myeloid · mixed phenotype acute leukemia,T/myeloid · mouth disorder · mucositis · mycosis fungoides and variants · myelodysplastic/myeloproliferative disease · myeloproliferative neoplasm · myofascial pain syndrome · neoplasm of mediastinum · nephrosis · nephrotic syndrome · neuralgia · neuritis · nodular lymphocyte predominant Hodgkin lymphoma · noise induced hearing loss · nutritional deficiency disease · obstetric disorder · obstructive lung disease · ocular hypertension · odontogenic cyst · open-angle glaucoma · opsoclonus-myoclonus syndrome · orbital cellulitis · Osgood-Schlatter disease · otitis media · otomycosis · ovarian clear cell tumor · ovarian hyperstimulation syndrome · ovarian serous tumor · palmar fibromatosis · panuveitis · paralytic ileus · pericarditis · peripheral nerve lesion · peripheral neuropathy · persistent tachypnoe of infancy · phacoanaphylactic uveitis · plantar fasciitis · post-cardiac arrest syndrome · post-transplant lymphoproliferative disease · postoperative ventricular dysfunction · preterm premature rupture of the membranes · primary plasmacytoma of the bone · primary thrombocytopenia · pulmonary immaturity · pure red-cell aplasia · radial heads, posterior dislocation of · refractive error · relapsing-remitting multiple sclerosis · respiratory syncytial virus bronchiolitis · respiratory tract infectious disorder · retinal edema · retinal lattice degeneration · retinal perforation · retinopathy of prematurity · rhegmatogenous retinal detachment · rheumatic disorder · rosacea conjunctivitis · sarcoidosis · secondary hemophagocytic lymphohistiocytosis · senile cataract · sensorineural hearing loss disorder · severe acute respiratory syndrome · sickle cell disease · sleep disorder · small intestine lymphoma · spinal stenosis · spondylosis · stenosis of lacrimal punctum · subarachnoid hemorrhage · subcutaneous panniculitis-like T-cell lymphoma · Sydenham chorea · systemic lupus erythematosus · T-cell adult acute lymphocytic leukemia · T-cell and NK-cell neoplasm · temporomandibular joint disorder · temporomandibular joint dysfunction syndrome · testicular lymphoma · thrombocytopenia due to immune destruction · thrombocytopenic purpura · thyroid gland disorder · tinea infection · traumatic brain injury · trigeminal neuralgia · type 1 diabetes mellitus · ulcerative colitis · urinary bladder disorder · urticaria · uveitis · vestibular disorder · viral conjunctivitis · vitiligo · voice disorders · xerophthalmia · acute pharyngitis · aggressive B-cell non-Hodgkin lymphoma · alcohol dependence · anaphylaxis · aorta coarctation · autoinflammatory syndrome · BD syndrome · blepharoconjunctivitis · bone neoplasm · calcific tendinitis · cerebral toxoplasmosis · chalazion · chorioretinitis · cleft lip · conjunctival pterygium · de Quervain disease · dental pulp disorder · disorder of facial skeleton · early T cell progenitor acute lymphoblastic leukemia · eclampsia · endophthalmitis · epiphora due to excess lacrimation · esophageal cancer · generalized vitiligo · glioma · gout · high grade astrocytic tumor · hyperhidrosis palmaris ET plantaris · indomethacin embryofetopathy · inflammatory disease · influenza · inherited hemoglobinopathy · interstitial lung disease · intervertebral disk degenerative disorder · intestinal perforation · keloid · keloid formation · keratitis · keratoconjunctivitis · meralgia paresthetica · mucous membrane pemphigoid · myopathy · optic neuritis · oral cavity cancer · parathyroid gland disorder · pemphigus vulgaris · persistent idiopathic facial pain · post-surgical hypoinsulinemia · postherpetic neuralgia · primary angle-closure glaucoma · primary bacterial infectious disease · proliferative diabetic retinopathy · proliferative vitreoretinopathy · psoriasis · radiculitis · reactive airway disease · refractory hematologic cancer · renal fibrosis · respiratory system disorder · scorpion envenomation · sinusitis · skin infection · tibial collateral ligament bursitis · tick-borne encephalitis · transverse myelitis · trigger thumb · urinary tract infection · urinary tract obstruction · vernal keratoconjunctivitis · vestibular neuronitis · viral encephalitis
Investigated by
National Cancer Institute (NCI) · Celgene Corporation · M.D. Anderson Cancer Center · Allergan · Ocular Therapeutix, Inc. · Mayo Clinic
+1,302 more · Bristol-Myers Squibb · Amgen · Millennium Pharmaceuticals, Inc. · PETHEMA Foundation · Memorial Sloan Kettering Cancer Center · Dana-Farber Cancer Institute · Assiut University · Sanofi · Takeda · Children's Oncology Group · Emory University · Peking University People's Hospital · SWOG Cancer Research Network · Sun Yat-sen University · Weill Medical College of Cornell University · Institute of Hematology & Blood Diseases Hospital, China · Janssen, LP · Karyopharm Therapeutics Inc · University Health Network, Toronto · University of Chicago · AbbVie · Alliance for Clinical Trials in Oncology · Massachusetts General Hospital · Merck Sharp & Dohme LLC · Peking Union Medical College Hospital · Roswell Park Cancer Institute · Shandong University · University of Arkansas · Duke University · Samsung Medical Center · Yonsei University · Assistance Publique - Hôpitaux de Paris · Cairo University · Janssen Scientific Affairs, LLC · Nantes University Hospital · Novartis Pharmaceuticals · Seoul National University Hospital · St. Jude Children's Research Hospital · Ain Shams University · Chinese Academy of Medical Sciences · European Myeloma Network B.V. · Hospital for Special Surgery, New York · Otonomy, Inc. · Pfizer · Quince Therapeutics S.p.A. · The First Affiliated Hospital of Soochow University · The University of Hong Kong · University of Alabama at Birmingham · Barbara Ann Karmanos Cancer Institute · Beijing Tiantan Hospital · Eyegate Pharmaceuticals, Inc. · Fondazione EMN Italy Onlus · Fred Hutchinson Cancer Center · Janssen Pharmaceuticals · Janssen Research & Development, LLC · Johns Hopkins University · Multiple Myeloma Research Consortium · National Institute of Allergy and Infectious Diseases (NIAID) · Poznan University of Medical Sciences · Rigshospitalet, Denmark · University of Miami · Wake Forest University Health Sciences · Brigham and Women's Hospital · Eli Lilly and Company · French Innovative Leukemia Organisation · Genentech, Inc. · GlaxoSmithKline · H. Lee Moffitt Cancer Center and Research Institute · Intergroupe Francophone du Myelome · Montefiore Medical Center · National Heart, Lung, and Blood Institute (NHLBI) · OHSU Knight Cancer Institute · Tanta University · University Hospital, Toulouse · all 1,308 on the full record

Regulatory milestones approvals, filings & regulatory actions · 7 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansions (3) US (FDA) DEXTENZA 2019-06-20 – 2025-04-07 fda.gov
Label expansions (2) US (FDA) OZURDEX 2010-09-24 – 2014-06-28 fda.gov
Approved EU (EMA) Ozurdex 2010-07-26 europa.eu
Approved US (FDA) DECADRON 1958-10-30 fda.gov

Trials 1,737 · started per year

today
US approved 1958
EU approved 2010
1
4
1
5
1
9
7
5
15
9
24
11
26
21
30
40
39
41
58
41
59
57
68
61
72
86
83
85
82
84
104
106
78
91
72
83
69
1957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 030 trials
Phase 0 NCT07662200 Aug 2026 → Aug 2027 expected malignant germ cell tumor Ottawa Hospital Research Institute Not yet recruiting No outcome recorded
Phase 0 NCT07343817 Jul 2026 → Apr 2028 expected Ahmed Nassar Ibrahim Mohammed Not yet recruiting No outcome recorded
Phase 0 NCT07109258 May → Sep 2025 overdue Cairo University Recruiting No outcome recorded
Phase 0 NCT06428630 May 2025 → Sep 2026 lichen planus, oral Tufts University Withdrawn No outcome recorded
Phase 0 NCT06894069 Mar → May 2025 overdue University of Jordan Not yet recruiting No outcome recorded
Phase 0 NCT06432712 Jan 2025 Shoaib Rahim Unknown No outcome recorded
Phase 0 NCT06142396 Nov 2024 → Nov 2027 expected kidney failure, plasma cell myeloma Augusta University Recruiting No outcome recorded
Phase 0 NCT06556095 Sep 2024 → Jan 2026 The University of Texas Health Science Center at San Antonio Completed No outcome recorded
Phase 0 NCT05994183 Oct 2023 → Mar 2025 bronchiolitis IDeA States Pediatric Clinical Trials Network Withdrawn No outcome recorded
Phase 0 NCT06016465 Sep 2023 → Dec 2027 expected migraine disorder Texas Tech University Health Sciences Center, El Paso Recruiting No outcome recorded
Phase 1117 trials
Phase 1 NCT07341867 Aug 2026 → Mar 2028 expected plasma cell myeloma, triple-negative breast carcinoma Andrew Hantel, MD Not yet recruiting No outcome recorded
Phase 1 NCT07513129 Jun 2026 → Dec 2029 expected T-cell acute lymphoblastic leukemia M.D. Anderson Cancer Center Recruiting No outcome recorded
Phase 1 NCT07426042 Apr → May 2026 overdue Min Kyu Park Not yet recruiting No outcome recorded
Phase 1 NCT07014462 Sep 2025 → Jun 2029 expected acute myeloid leukemia University of Vermont Enrolling by invitation No outcome recorded
Phase 1 NCT07182110 Aug 2025 → Aug 2026 overdue gallbladder disorder Makassed General Hospital Active not recruiting No outcome recorded
Phase 1 NCT06348108 Jul 2025 → Jul 2027 expected plasma cell myeloma Alfred Chung, MD Recruiting No outcome recorded
Phase 1 NCT06863259 May 2025 → Jan 2028 expected B-cell acute lymphoblastic leukemia Children's Hospital Medical Center, Cincinnati Recruiting No outcome recorded
Phase 1 NCT05773664 Nov 2024 glioblastoma City of Hope Medical Center Withdrawn No outcome recorded
Phase 1 NCT06433947 Aug 2024 → Jul 2026 overdue plasma cell myeloma Opna Bio LLC Recruiting No outcome recorded
Phase 1 NCT06304909 May 2024 → Mar 2025 Assiut University Completed No outcome recorded
Show all 117 trials opens the full record — a long page
Phase 1/2101 trials
Phase 1/2 NCT06574048 Jul 2026 → Jul 2027 expected carbon monoxide-induced parkinsonism University of Nebraska Not yet recruiting No outcome recorded
Phase 1/2 NCT07479979 Jul 2026 → Jul 2027 expected plasma cell myeloma Natalie Callander Recruiting No outcome recorded
Phase 1/2 NCT07601100 Jun 2026 → Jul 2029 expected plasma cell myeloma Dana-Farber Cancer Institute Not yet recruiting No outcome recorded
Phase 1/2 NCT06930690 Jun → Dec 2026 expected The Methodist Hospital Research Institute Recruiting No outcome recorded
Phase 1/2 NCT07504822 Apr 2026 → Mar 2027 expected acne Yohanes Firmansyah, dr, MH, MM Not yet recruiting No outcome recorded
Phase 1/2 NCT07388069 Dec 2025 → Dec 2026 expected keratoconus TheiaNova Ltd. Enrolling by invitation No outcome recorded
Phase 1/2 NCT06892522 Jun 2025 → Feb 2036 expected plasma cell myeloma AbbVie Recruiting No outcome recorded
Phase 1/2 NCT06235567 Apr 2025 → Aug 2026 overdue keratoconus Maanasa Indaram, MD Enrolling by invitation No outcome recorded
Phase 1/2 NCT07024043 Mar → Sep 2025 overdue Ain Shams University Active not recruiting No outcome recorded
Phase 1/2 NCT06176027 Oct 2024 → Sep 2028 expected peripheral T-cell lymphoma, not otherwise specified Navy General Hospital, Beijing Recruiting No outcome recorded
Phase 2629 trials
Phase 2 NCT07605416 Jul 2026 → Nov 2032 expected plasma cell leukemia National Cancer Institute (NCI) Not yet recruiting No outcome recorded
Phase 2 NCT07588698 Jul 2026 → Jul 2028 expected diffuse large B-cell lymphoma Mwanasha Merrill, MD Not yet recruiting No outcome recorded
Phase 2 NCT07698080 Jul 2026 → Jul 2028 expected aplastic anemia, leukemia, lymphoma, myelodysplastic syndrome +1 Hematology department of the 920th hospital Not yet recruiting No outcome recorded
Phase 2 NCT06818981 Jul 2026 → Jun 2027 expected obstructive sleep apnea syndrome Medical University of South Carolina Not yet recruiting No outcome recorded
Phase 2 NCT06348147 Jul 2026 → May 2027 disease related to hematopoietic stem cell transplant, plasma cell myeloma UNC Lineberger Comprehensive Cancer Center Withdrawn No outcome recorded
Phase 2 NCT07652879 Jun 2026 → Jan 2028 expected POEMS syndrome Shanghai Changzheng Hospital Recruiting No outcome recorded
Phase 2 NCT07643103 Jun 2026 → May 2028 expected precursor B-cell acute lymphoblastic leukemia Institute of Hematology & Blood Diseases Hospital, China Not yet recruiting No outcome recorded
Phase 2 NCT07604987 May 2026 → May 2028 expected primary central nervous system lymphoma Zou Dehui Recruiting No outcome recorded
Phase 2 NCT07567274 May → Jul 2026 overdue tinnitus Leading Edge Clinic Enrolling by invitation No outcome recorded
Phase 2 NCT07548736 Apr 2026 → Apr 2027 expected enterocolitis Sixth Affiliated Hospital, Sun Yat-sen University Not yet recruiting No outcome recorded
Show all 629 trials opens the full record — a long page
Phase 2/345 trials
Phase 2/3 NCT07095452 Jan 2026 → Jan 2042 expected plasma cell myeloma AbbVie Recruiting No outcome recorded
Phase 2/3 NCT07059156 Jun 2025 → Jun 2027 expected adult acute lymphoblastic leukemia Shanxi Bethune Hospital Recruiting No outcome recorded
Phase 2/3 NCT07343128 Jun → Dec 2025 fibromyalgia Sanliurfa Education and Research Hospital Completed No outcome recorded
Phase 2/3 NCT06212336 May 2025 → Jun 2027 expected Lassa fever Irrua Specialist Teaching Hospital Recruiting No outcome recorded
Phase 2/3 NCT06913374 May 2025 → May 2026 overdue primary thrombocytopenia Shandong University Not yet recruiting No outcome recorded
Phase 2/3 NCT06879379 Mar 2025 → Mar 2028 expected plasma cell myeloma Peking University People's Hospital Recruiting No outcome recorded
Phase 2/3 NCT07290595 Jan 2025 → Feb 2026 overdue hypotensive disorder Sahiwal medical college sahiwal Recruiting No outcome recorded
Phase 2/3 NCT06621329 Oct 2024 → Jul 2026 overdue headache disorder, subarachnoid hemorrhage University of California, Davis Recruiting No outcome recorded
Phase 2/3 NCT06496997 Aug 2024 → Aug 2025 overdue acute respiratory distress syndrome Fayoum University Recruiting No outcome recorded
Phase 2/3 NCT07368075 Jul 2024 → Oct 2025 hypotensive disorder Sahiwal medical college sahiwal Completed No outcome recorded
Phase 3269 trials
Phase 3 NCT07543458 Oct 2026 → Jul 2030 expected arbovirus infection, dengue disease, hemorrhagic fever Oxford University Clinical Research Unit, Vietnam Not yet recruiting No outcome recorded
Phase 3 NCT07674576 Sep 2026 → Aug 2028 expected CMC Ambroise Paré Not yet recruiting No outcome recorded
Phase 3 NCT07576660 Jul 2026 → Sep 2029 expected acute respiratory distress syndrome Southeast University, China Not yet recruiting No outcome recorded
Phase 3 NCT07665762 Jun 2026 → Sep 2028 expected The University of Hong Kong Not yet recruiting No outcome recorded
Phase 3 NCT07624513 Jun 2026 → Oct 2033 expected plasma cell myeloma Dana-Farber Cancer Institute Not yet recruiting No outcome recorded
Phase 3 NCT07413055 Mar → Nov 2026 expected Oman Ministry of Health Recruiting No outcome recorded
Phase 3 NCT06511765 Mar → Sep 2026 expected lumbar disk disease Elsan Recruiting No outcome recorded
Phase 3 NCT07052201 Feb 2026 → Jan 2028 expected bronchopulmonary dysplasia The Children's Hospital of Zhejiang University School of Medicine Not yet recruiting No outcome recorded
Phase 3 NCT07708142 Jan 2026 → Jul 2027 expected retinal vein occlusion SANGMYUNG innovation Recruiting No outcome recorded
Phase 3 NCT07222761 Jan 2026 → May 2029 expected refractory plasma cell neoplasm Regeneron Pharmaceuticals Recruiting No outcome recorded
Show all 269 trials opens the full record — a long page
Phase 4323 trials
Phase 4 NCT07605065 Nov 2026 → Feb 2027 expected headache disorder Pak Emirates Military Hospital Not yet recruiting No outcome recorded
Phase 4 NCT07614802 Aug 2026 → Aug 2027 expected Duke University Not yet recruiting No outcome recorded
Phase 4 NCT07064993 Jul 2026 → Feb 2027 expected Arzu Esen Tekeli Not yet recruiting No outcome recorded
Phase 4 NCT07699744 Jul 2026 → Jun 2027 expected rotator cuff syndrome Seoul National University Hospital Not yet recruiting No outcome recorded
Phase 4 NCT07709884 Jul 2026 → Dec 2028 expected plasma cell myeloma The First Affiliated Hospital of Soochow University Not yet recruiting No outcome recorded
Phase 4 NCT07699315 Jul → Dec 2026 expected pulpitis Watim Medical & Dental College Not yet recruiting No outcome recorded
Phase 4 NCT07357597 Jun 2026 → Jan 2028 expected stomatitis AstraZeneca Recruiting No outcome recorded
Phase 4 NCT07554963 May → Oct 2026 expected impacted teeth, multiple Hayat Abad Medical Complex, Peshawar Not yet recruiting No outcome recorded
Phase 4 NCT07494136 May 2026 → May 2027 expected radiculopathy, sciatica University of Miami Not yet recruiting No outcome recorded
Phase 4 NCT07556952 Apr 2026 → Mar 2028 expected chronic pain syndrome McGill University Health Centre/Research Institute of the McGill University Health Centre Recruiting No outcome recorded
Show all 323 trials opens the full record — a long page
Phase not applicable217 trials
NCT07435493 Nov 2026 expected adenoid hypertrophy, obstructive sleep apnea syndrome Ain Shams University Not yet recruiting No outcome recorded
NCT07498998 Jul → Aug 2026 overdue carpal tunnel syndrome Tanta University Not yet recruiting No outcome recorded
NCT07631910 Jul → Oct 2026 expected Sir Run Run Shaw Hospital Not yet recruiting No outcome recorded
NCT07677215 Jul 2026 → Sep 2027 expected osteoarthritis, knee Poznan University of Medical Sciences Not yet recruiting No outcome recorded
NCT07672873 Jun → Dec 2026 expected pulpitis Marmara University Recruiting No outcome recorded
NCT07341854 Jun 2026 → Jun 2027 expected neuropathy, painful Beijing Tiantan Hospital Not yet recruiting No outcome recorded
NCT07550803 Jun 2026 → Jun 2027 expected sleep disorder Seoul National University Hospital Not yet recruiting No outcome recorded
NCT07584200 Jun 2026 → Mar 2027 expected osteoarthritis, hip Poznan University of Medical Sciences Not yet recruiting No outcome recorded
NCT07607691 Jun → Oct 2026 expected bursitis, chronic pain syndrome, frozen shoulder, rotator cuff syndrome Ankara City Hospital Bilkent Not yet recruiting No outcome recorded
NCT07525934 Apr → Jul 2026 overdue Recep Karakaşoğlu Not yet recruiting No outcome recorded
Show all 217 trials opens the full record — a long page
Phase not stated6 trials
NCT03969875 Aug 2018 → Apr 2022 osteoarthritis Icahn School of Medicine at Mount Sinai Completed No outcome recorded
NCT04534322 refractory plasma cell neoplasm Oncopeptides AB Approved for marketing No outcome recorded
NCT02856438 plasma cell myeloma Bristol-Myers Squibb No longer available No outcome recorded
NCT00517894 lymphoma Study Group of Medical Tumour Therapy (AGMT) No longer available No outcome recorded
NCT01250808 plasma cell myeloma Peking University Available No outcome recorded
NCT02368301 plasma cell myeloma Bristol-Myers Squibb No longer available No outcome recorded
Also used as a comparator or background therapy in 1,879 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 020 trials
Phase 0 NCT07485127 Comparator Feb → Aug 2026 overdue Sohag University Active not recruiting No outcome recorded
Phase 0 NCT05287035 Comparator Jul 2023 → Jan 2025 University of Texas at Austin Unknown No outcome recorded
Phase 0 NCT05687981 Comparator Jan → Dec 2023 Tanta University Unknown No outcome recorded
Phase 0 NCT05305404 Comparator Mar 2022 → Jun 2024 alcohol dependence Stony Brook University Unknown No outcome recorded
Phase 0 NCT05142098 Comparator Jan → Jul 2022 Dow University of Health Sciences Unknown No outcome recorded
Phase 1205 trials
Phase 1 NCT07609706 Background Oct 2026 → Aug 2031 expected plasma cell myeloma GlaxoSmithKline Not yet recruiting No outcome recorded
Phase 1 NCT07444710 Background Aug 2026 → Sep 2027 expected mantle cell lymphoma National Cancer Institute (NCI) Not yet recruiting No outcome recorded
Phase 1 NCT07608731 Background Jun 2026 → Apr 2029 expected diffuse large B-cell lymphoma of the central nervous system, large B-cell lymphoma Allison Winter Not yet recruiting No outcome recorded
Phase 1 NCT07082270 Background Apr 2026 → Feb 2028 plasma cell myeloma Roswell Park Cancer Institute Withdrawn No outcome recorded
Phase 1 NCT07380139 Comparator Feb → Dec 2026 expected Ain Shams University Enrolling by invitation No outcome recorded
Show all 205 trials opens the full record — a long page
Phase 1/2181 trials
Phase 1/2 NCT06437054 Background Dec 2026 sensorineural hearing loss disorder, sudden hearing loss disorder Seoul National University Hospital Withdrawn No outcome recorded
Phase 1/2 NCT07600151 Background Dec 2026 → Sep 2036 expected plasma cell myeloma University Medical Center Hamburg-Eppendorf Not yet recruiting No outcome recorded
Phase 1/2 NCT07175415 Background Oct 2026 → Oct 2031 expected T lymphoblastic leukemia/lymphoma, acute lymphoblastic leukemia Princess Maxima Center for Pediatric Oncology Not yet recruiting No outcome recorded
Phase 1/2 NCT07463807 Comparator Jul → Aug 2026 overdue plasma cell myeloma National Cancer Institute (NCI) Not yet recruiting No outcome recorded
Phase 1/2 NCT07387926 Background Jul 2026 → Sep 2033 expected B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2), acute lymphoblastic leukemia Novartis Pharmaceuticals Recruiting No outcome recorded
Show all 181 trials opens the full record — a long page
Phase 2432 trials
Phase 2 NCT07636564 Background Oct 2026 → Apr 2031 expected B-cell acute lymphoblastic leukemia, T-cell acute lymphoblastic leukemia, acute leukemia of ambiguous lineage SWOG Cancer Research Network Not yet recruiting No outcome recorded
Phase 2 NCT07694089 Comparator Oct 2026 → Aug 2029 expected high grade astrocytic tumor Akshitkumar MIstry Not yet recruiting No outcome recorded
Phase 2 NCT06948084 Comparator Aug 2026 → Feb 2028 expected plasma cell myeloma National Cancer Institute (NCI) Not yet recruiting No outcome recorded
Phase 2 NCT07709000 Background Aug 2026 → Nov 2033 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Merck Sharp & Dohme LLC Not yet recruiting No outcome recorded
Phase 2 NCT07614360 Background Aug 2026 → Feb 2029 expected plasma cell myeloma GlaxoSmithKline Not yet recruiting No outcome recorded
Show all 432 trials opens the full record — a long page
Phase 2/346 trials
Phase 2/3 NCT07072585 Background Aug 2026 → Sep 2035 expected T-cell acute lymphoblastic leukemia, T-lymphoblastic lymphoma Children's Oncology Group Not yet recruiting No outcome recorded
Phase 2/3 NCT07428369 Comparator Jun 2026 → May 2038 plasma cell myeloma Regeneron Pharmaceuticals Withdrawn No outcome recorded
Phase 2/3 NCT07570173 Background May 2026 → Oct 2033 expected B-cell acute lymphoblastic leukemia Merck Sharp & Dohme LLC Recruiting No outcome recorded
Phase 2/3 NCT07542288 Comparator Apr 2026 → Jun 2028 expected metastatic malignant neoplasm in the brain The Second Affiliated Hospital of Hainan Medical University Not yet recruiting No outcome recorded
Phase 2/3 NCT07185373 Background Oct 2025 → Sep 2028 expected primary central nervous system lymphoma Huashan Hospital Not yet recruiting No outcome recorded
Phase 3441 trials
Phase 3 NCT07709715 Comparator Jan 2027 → Dec 2028 expected AL amyloidosis Nexcella Inc. Not yet recruiting No outcome recorded
Phase 3 NCT07665450 Comparator Sep 2026 → Sep 2030 expected plasma cell myeloma Janssen Research & Development, LLC Not yet recruiting No outcome recorded
Phase 3 NCT06980727 Comparator Aug 2026 → Dec 2027 expected urinary tract obstruction University of Monastir Not yet recruiting No outcome recorded
Phase 3 NCT07579351 Comparator Aug 2026 → Jul 2028 expected sciatica Semnur Pharmaceuticals, Inc. Not yet recruiting No outcome recorded
Phase 3 NCT07678229 Comparator Jul 2026 → Dec 2031 expected mature T-cell and NK-cell non-Hodgkin lymphoma Rong Tao Not yet recruiting No outcome recorded
Show all 441 trials opens the full record — a long page
Phase 4313 trials
Phase 4 NCT07097493 Comparator Aug → Dec 2026 expected osteoarthritis, knee Wake Forest University Health Sciences Not yet recruiting No outcome recorded
Phase 4 NCT07228052 Comparator Jul → Dec 2026 expected asthma Montefiore Medical Center Not yet recruiting No outcome recorded
Phase 4 NCT07639723 Background Jul 2026 → Jul 2027 expected Endeavor Health Not yet recruiting No outcome recorded
Phase 4 NCT07638527 Comparator Jul 2026 → Feb 2027 expected Faisalabad Medical University Not yet recruiting No outcome recorded
Phase 4 NCT07469488 Background Apr 2026 → Aug 2029 expected non-small cell lung carcinoma, toxic dermatosis, venous thromboembolism Shanghai Pulmonary Hospital, Shanghai, China Not yet recruiting No outcome recorded
Show all 313 trials opens the full record — a long page
Phase not applicable239 trials
NCT07454226 Background May 2026 → Mar 2028 expected acute lymphoblastic leukemia, phosphohydroxylysinuria Institute of Hematology & Blood Diseases Hospital, China Recruiting No outcome recorded
NCT07581470 Comparator May 2026 → Jun 2027 expected osteoarthritis, hip Poznan University of Medical Sciences Recruiting No outcome recorded
NCT07558226 Comparator May 2026 → Nov 2027 expected Fundacio Puigvert Recruiting No outcome recorded
NCT07442890 Background Apr 2026 → Apr 2028 expected lung cancer Henan Cancer Hospital Not yet recruiting No outcome recorded
NCT07509866 Comparator Apr → Oct 2026 expected Huazhong University of Science and Technology Recruiting No outcome recorded
Show all 239 trials opens the full record — a long page
Phase not stated2 trials
NCT03763370 Background plasma cell myeloma GlaxoSmithKline Available No outcome recorded
NCT02666209 Background plasma cell myeloma Dana-Farber Cancer Institute No longer available No outcome recorded

Press releases naming this drug 12 releases

DateIssuerRelease
2021-12-01 Amgen FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and dexamethasone For Patients With Multiple Myeloma At First Or Subsequent Relapse amgen.com
2021-03-31 Sanofi FDA approves Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma sanofi.com
2021-02-26 Sanofi Media Update: CHMP recommends approval of Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for the treatment of relapsed multiple myeloma sanofi.com
2020-08-20 Amgen FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX® (daratumumab) And Dexamethasone In Both Once- And Twice-Weekly Dosing Regimens amgen.com
2018-10-01 Amgen FDA Approves KYPROLIS® (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma amgen.com
2018-08-27 Amgen Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone amgen.com
2018-06-08 Amgen European Commission Approves Prolia® (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis amgen.com
2018-05-21 Amgen FDA Approves Prolia® (Denosumab) For Glucocorticoid-Induced Osteoporosis amgen.com
2018-04-27 Amgen Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia® (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis amgen.com
2017-10-09 Amgen FDA Accepts Supplemental Biologics License Application For Prolia® (Denosumab) In Glucocorticoid-Induced Osteoporosis amgen.com
2017-07-31 Amgen Amgen Submits Supplemental Biologics License Application For Prolia® (denosumab) In Glucocorticoid-Induced Osteoporosis amgen.com
2016-08-29 Amgen Amgen Announces Positive Top-Line Results From Phase 3 Study Of Prolia® (Denosumab) In Patients Receiving Glucocorticoid Therapy amgen.com

Evidence & citations 110 cited values

Every value below carries the sentence it was read from. 3,642 sources stand behind the page.

FieldValueCited text
Known as dexamethasone “including but not limited to DHAP (dexamethasone, cisplatin, high-dose cytarabine), ESHAP (etoposide, methylprednisolone, high-dose cytarabine and cisplatin), DICE...” NCT04486391
3500

“Standard Induction chemotherapy care included: vincristine, doxorubicin, and dexamethasone (VAD) (0.5 mg, 10 mg/m2, and 40 mg, respectively);dexamethasone,...” NCT00577096

“The study aims to evaluate the efficacy and safety of the quadruplet regimen Isatuximab in combination with Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRD) compared to...” NCT07334535

“This is a randomized, controlled study to assess the safety and effectiveness of treatment with an intracanalicular dexamethasone (0.4mg) insert when utilized in conjunction...” NCT05665270

“Topical moxifloxacin 0.5% (Vigamox; Alcon Laboratories) four times per day, artificial tears (Systane Ultra; Alcon) every two hours, Dexamethasone 0.1% (Maxidex; Alcon...” NCT05331859

“Recommended rescue medications include tocilizumab for treatment of cytokine release syndrome (CRS); dexamethasone, acetaminophen, and diphenhydramine for CRS/infusion-related...” NCT07227597

“This is a randomized phase III trial of CC-5013 (lenalidomide, NSC-703813) and low dose dexamethasone (LLD) versus bortezomib (PS-341, NSC-681239), lenalidomide and low dose...” NCT01530594

“OZURDEX® (DEX implant, 0.7 mg) is a micro-ionized and non-preserved dexamethasone within a cylindrically-shaped 0.45 mm diameter x 6.5 mm length biodegradable Poly D,...” NCT03629210

“Patients randomized to receive corticosteroids will receive dexamethasone 20mg daily for 5 days and then 10mg for an additional 5 days, for a total of 10 days from the time of...” NCT05440851

“The medical intervention consists of intravenous dexamethasone (10 mg if bodyweight \< 70 kilograms, 20 mg if bodyweight \> 70 kilograms), intravenous cefazolin 2 grams,...” NCT04998513

“The purpose of this study is to find out what the response is and the side effects are with chemotherapy using a combination of drugs called D.T. PACE (Dexamethasone,...” NCT00107614

“The purpose of this study is to find out whether Tec-RVd (teclistamab, lenalidomide, bortezomib, and dexamethasone) after 3 treatment Cycles of Dara-RVd (daratumumab,...” NCT07099391

“Thirty-three newly diagnosed, symptomatic patients with MM received bortezomib 1.3 mg/m(2) intravenously on days 1, 4, 8 and 11, cyclophosphamide 300 mg/m(2) orally on days 1,...” PMID 19225538 Feb 2009

“Before the use of utidelone, all patients will accept pretreatment: diphenhydramine 40 mg by intramuscular injection or oral administration, and dexamethasone10 mg and...” NCT05866510

“One hundred and twenty four patients received one of the three IANB injections before the endodontic treatment: 2% lidocaine with 1:80 000 epinephrine; 2% lidocaine with 1:80...” NCT05361291

“After enrollment and randomization, patients assigned to corticosteroid therapy will receive it as a single-bolus intravenous injection of dexamethasone 20 mg (day 1), followed...” NCT05809011

“USG with a 25G needle, Bupivacaine 0.5% 30ml with 4mg preservative free dexamethasone divided as follows into the following 5 nerves: Posterior Tibial nerve (10ml), Saphenous...” NCT05368012

“R-IDARAM comprised of rituximab 375 mg/m2 (day 1), idarubicin 10 mg/m2(day 2 and 3); dexamethasone 100 mg/m2 (12 h.infusion in day 2, 3 and 4); cytarabine 1 g/m2 (1 h. infusion...” NCT02657785

“Patients will receive APG-2575 at target dose once daily for 28 days plus pomalidomide (4 mg ) on Days 1 through 21 and dexamethasone (40 mg for patients ≤ 75 years old or 20...” NCT04942067

“rituximab and modified hyperfractionated cyclophosphamide, vincristine doxorubicin, dexamethasone (hyperCVAD) administered every 28 days for 4-6 cycles followed by rituximab...” NCT00581854

“R-IDARAM comprised of rituximab 375 mg/m2 (day 1), idarubicin 10 mg/m2(day 2); dexamethasone 100 mg/m2 (12 h.infusion in day 2, 3 and 4); cytarabine 1 g/m2 (1 h. infusion in...” NCT02836158

“Patients with a persistently positive interim-PET scan assigned to arm B2 will receive six blocks of the B-ALL protocol (rituximab, methotrexate, ifosfamide, etoposide,...” NCT00554164

“Recommended rescue medications are pegfilgrastim or equivalent, histamine-1 (H1) receptor antagonist, histamine-2 (H2) receptor antagonist, acetaminophen or equivalent,...” NCT07419295

“Epidural steroid injectate will be 2cc of 1% lidocaine followed by 1-3 cc of 40 mg/cc Kenalog (i.e. 40-120 mg Kenalog) or an equivalent steroid medication (depo-medrol 60-120...” NCT01238536

“Opioid-Free Multimodal Analgesia will receive preoperative acetaminophen (15 mg/kg) and ibuprofen (10 mg/kg), intraoperative ketamine (0.5 mg/kg IV) and dexamethasone (0.1...” NCT07435493

“The investigator prospectively evaluated the combination of Rituximab and Dexa-BEAM (dexamethasone, carmustine, etoposide, cytarabine, melphalan) followed by high dose therapy...” NCT02099292

“The purpose of this study is to evaluate the efficacy and safety of NXC-201 compared with Dara-CyBorD (daratumumab-cyclophosphamide-bortezomib-dexamethasone) in the treatment...” NCT07709715

“Patient eligible to enter the study will receive 9 to 12 cycles (according to response) of intravenous Isatuximab (10 mg/kg) and oral Pomalidomide 4 mg from day 1 to day 21 and...” NCT05066607

“Participants instructed to instill 1 drop of SHP640 (Povidone-iodine \[PVP-I\] 0.6 percent \[%\] and Dexamethasone 0.1%) ophthalmic suspension in each eye 4 times daily (QID)...” NCT02998554

“1ml dexamethasone mixed with 0.5-2ml of saline to achieve the same injection volume with the cell suspension (which contains betamethasone dipropionate 5mg and betamethasone...” NCT03279796

“Intraoperative time: intravenous ketamine 0.5 mg kg-1, intravenous dexamethasone 8 mg Postoperative time: paracetamol 1 g every 6 hours a day, nefopam 20 every 8 hours a day,...” NCT06381063

“Patients were treated by Azacytidine(75 mg/m2 on days 1-7) plus CAOLD regimen (cyclophosphamide 400mg/m2 qd d1; cytarabine 30mg/m2 qd d1-d4; vindesine 2mg/m2 qd d1;...” NCT06176027

“Induction therapy consist of bortezomib, lenalidomide, and dexamethasone (VRd) or daratumumab, lenalidomide, and dexamethasone (DRd) or daratumumab, bortezomib, lenalidomide,...” NCT07149857

“Pretreatment: diphenhydramine 40 mg by intramuscular injection or oral administration, and dexamethasone10 mg and cimetidine 300 mg by intravenous injection 30 minutes prior to...” NCT05673590

“Initially Dexamethasone 6x per day for 2 weeks followed by 4x per day for one month, 3x per day for one month, 2x per day for one month, and finally 1x per day for one month -...” NCT01682421

“This study will investigate the efficacy and safety of OZURDEX® (dexamethasone intravitreal implants; DEX, Allergan, Inc. Irvine, CA) as monotherapy for the treatment of...” NCT05101928

“This prospective, single-center, open-label, investigator-sponsored clinical study seeks to investigate the outcomes of patients undergoing vitro-retinal surgery with the...” NCT04462523

“For relapsed refractory MCL patients who had received BTK inhibitors: selinexor 60mg once daily on days 1 and 8, zuberitamab 375 mg/m² on day 0, Dexamethasone 20 mg on days 1-3...” NCT07264894

“Adjunctive corticosteroids to be dosed at 0.4mg/kg/day of dexamethasone or equivalent for week 1, then 0.3mg/kg/day for week 2, 0.2mg/kg/day for week 3, 0.1mg/kg/day for week...” NCT06446245

“Once the patient has started the study treatment, the dose of corticosteroids will be tapered every 5 days (e.g., dexamethasone 2 mg or prednisone 15 mg per taper), as...” NCT02490878

“R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) administered in 3 week cycles for 3 cycles R-HAD (rituximab, cytarabine, dexamethasone) administered...” NCT01865110

“In addition, dexamethasone, a drug used to prevent nausea and vomiting in chemotherapy patients that may have protective effects on the liver, will be administered to patients...” NCT01273480

“Radiotherapy Technique: IMRT Total dose: 50 Gy Per fraction: 2 Gy Chemotherapy: q3w Dexamethasone 40 mg d1-4 Ifosfamide 1200mg/m2 d1-4 Etoposide 60 mg/m2 d1-4 Cisplatin 20mg/m2...” NCT01667302

“To determine patient preference and treatment outcomes with an intracanalicular dexamethasone (0.4mg) insert compared to standard steroid drop regimen in the contralateral eye...” NCT04396990

“Comparing the Effects of Ondansetron Versus Dexamethasone on the Incidence of Post-dural Puncture Headache (PDPH) , Nausea and Vomiting After Spinal Anaesthesia of Parturients...” NCT05202574

“DHAP regimen: dexamethasone - 40 mg on days 1, 2, 3, and 4 of dosing cycle; cisplatin - 100 mg/m2/24hrs continuous on day 1 of dosing cycle; cytarabine - 2g/m2 q12 hrs (2...” NCT01014208

“Placebo, given orally Ranitide 50 mg, IV, before chemotherapy (D1) Ondansetron 8 mg, IV, before chemotherapy (D1) Dexamethasone 10 mg, IV, before chemotherapy (D1)...” NCT01052844

“R-HCVAD - Rituximab (375 mg/m2), Cyclophosphamide (300 mg/m2), Mesna (600 mg/m2), Doxorubicin (50 mg/m2), Vincristine (2 mg total), Dexamethasone (40 mg total), Methotrexate...” NCT01854372

Dexamethasone, a potent synthetic glucocorticoid with minimal mineralocorticoid effects, is commonly administered as an anesthesia adjunct for the prevention of postoperative...” NCT02112422

“Patients receive concurrent aprepitant 125mg, dexamethasone 12mg, and ondansetron 8mg p.o. on day1. AND then patients received aprepitant 80mg, dexamethasone 8mg on day 2-5 at...” NCT03572829

“Participants are required to receive prophylactic mouthwash (steroid mouthwash \[dexamethasone or equivalent\] is highly recommended) to mitigate the onset and severity of...” NCT06356311

“This study will compare the efficacy and safety of low dose chidamide combined with high-dose dexamethasone versus high-dose dexamethasone monotherapy in adults with primary...” NCT05411874

“with varied cycles, including Daunorubicin, Vincristine, Prednisone, Pegaspargase, Rituximab, Cytarabine, Mercaptopurine, Cyclophosphamide, Methotrexate, Doxorubicin,...” NCT04845035

“Patients would receive a single intravenous infusion of HR20013 (Day 1) before cisplatin-based chemotherapy, alongside oral dexamethasone (Day 1, 12 mg, once a day; Day 2-4,...” PMID 40866861 Aug 2025

“Used drugs are rituximab,cyclophosphamide, prednisone, dexamethasone, vincristine, methotrexate, iphosphamide, teniposide, etoposide, dexamethasone, cytarabine,adriamycin,...” NCT01290120

“Torisel in association with Rituximab-Aracytine (high dose)-Dexamethasone (R-DHA) administered every 4 weeks (28 days) for 6 cycles for patients in relapsed/refractory Mantle...” NCT01389427

“Three courses of VCD (sc bortezomib 1.3 mg/sqm days 1, 4, 8, 11, iv cyclophosphamide 500 mg/sqm on days 1 and 8, and p.o. dexamethasone 40 mg days 1, 2, 4, 5, 8, 9, 11, 12 in...” NCT02573935

“This trial is to evaluate the efficacy of concurrent chemoradiotherapy with cisplatin followed by VIPD (etoposide, ifosfamide, cisplatin, dexamethasone) in localized NK/T-cell...” NCT00418535

“cyclophosphamide, anthracene nucleus chemotherapeutics(doxorubicin,liposomal doxorubicin, etc.), vinca alkaloids(vincristine, vindesine, etc.),and glucocorticoid...” NCT05498259

“Chemotherapy is DHAOx at days 71, 113 and 155 (oxaliplatin (130 mg/m2, day 1) and cytarabine (ARA-C, 2x 1000 mg/m2 at day 2) dexamethasone PO (40 mg/m2, day 1)), as per...” NCT02042391

“Day 1: Aprepitant 125mg QD (once daily); Ondansetron 8mg BD (twice daily); Dexamethasone 12mg QD (Aprepitant, Ondansetron and Dexamethasone to be take 60 minutes before...” NCT07455955

“induction therapy using the combination of dexamethasone, lenalidomide (revlimid), daratumumab (Darzalex) and carfilzomib (Kyprolis) to treat patients with newly diagnosed...” NCT03224507

“Chemotherapy agents for reinduction include vincristine, dexamethasone, polyethylene glycol (PEG)-asparaginase (Erwinia asparaginase when PEG-asparaginase is not available),...” NCT04501614

“Patients will receive a 5mL injection comprised of 4.5mL 1% bupivacaine and 0.5mL of dexamethasone (10mg/mL) directed towards the sphenopalatine ganglion on each side (5 mL on...” NCT04331938

“Rituximab combined with Chemotherapy (Rituximab, Cyclophosphamide, doxorubicin, Vincristine, Prednisone, Ifosfamide, Gemcitabine, cisplatin, Carboplatin, Etoposide, MESNA,...” NCT07187960

“Dexalgen® will be administered at a dose equivalent to dexamethasone 1.5 mg, dipyrone 500 mg, and hydroxocobalamin 5 mg (one ampoule for each type) a day at a single intramuscular dose” NCT01147289

“Intravenous administration of paracetamol 1 g, morphine 0.1 mg/kg, dexamethasone 8 mg, and ketamine 0.5 mg/kg bolus followed by 0.3 mg/kg/h infusion for postoperative pain management.” NCT07455565

“intravenous dexamethasone at a dose of 10 mg 30 minutes prior to chemotherapy on Day 1, followed by intravenous dexamethasone at a dose of 8 mg on days 2, 3, and 4 post-chemotherapy.” NCT06314906

“The purpose of this study is to determine whether an intravitreal dexamethasone implant (Ozurdex, Allergan) is effective to manage macular edema secondary to non-infectious uveitis.” NCT01870440

“Prednisone/prednisolone 5 mg tablet orally twice daily/dexamethasone 0.5 mg tablet orally once daily continuously in 28-day cycle up to disease progression, death, or end of study.” NCT00474383

“Phase II Clinical Study of Daratumumab Combined With Bortezomib, Lenalidomide and Dexamethasone (DVRd) in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma” NCT06158269

“ZR2:Rituximab 375mg/m2, D1, Lenalidomide 24mg qd D1-14, zebutinib 160mg bid RDHAP:Rituximab 375mg/m2 D0, dexamethasone 40mg D1-4, cytarabine 2g/m2 q12h D2, cisplatin 25mg/m2 D1-3.” NCT05992597

“Intravenous administration of Actovegin, vitamins B1, B6, B12, C, oxytocin/dexamethasone, calcium gluconate, etc in 250 ml normal saline administered during approximately 2 hours” NCT03543917

“Thalidomide, day 1 cycle 1, 100 mg/24 h. oral, in combination with cyclophosphamide and dexamethasone. If toxicity is <Grade 2, dose should be increased to 200 mg/24 h. in day 15” NCT00652041

“compare the effectiveness of supra periosteal injection of dexamethasone versus placebo in reducing post operative pain in teeth diagnosed with symptomatic irreversible pulpitis” NCT07233564

“Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)” NCT03964090

“Ibuprofen (Peinlos) 2x400 mg iv, Paracetamol (Bernofarm) 2x1 gr iv, dexamethasone (Phapros) 2x5 mg iv will be given with interval 8 hour, within the IBU-PCT-DEX intervention.” NCT06604598

Dexamethasone will be administered on the days of isatuximab administration and can be discontinued after two cycles of therapy, or continued at discretion of investigator.” NCT06517017

“After removal of thyroid gland, 8mg of dexamethasone will be diluted in 100cc of irrigation water and irrigate the operative field for 1 minute for the intervention group.” NCT07068048

“A strip of neomycin sulfate, polymyxin B sulfate, and dexamethasone ophthalmic ointment will be then applied into the lower conjunctival fornix to patients in both groups.” NCT02424357

“Patients randomized to receive an ONB will receive the block with dexamethasone 2mg (steroid) each site with 3ml 1% lidocaine (local anesthetic), for a total of two sites.” NCT03007420

“10mg of dexamethasone (1cc) mixed with 1cc of 2% preservative-free xylocaine (lidocaine) will be injected on each side of the stenotic segment under fluoroscopic guidance” NCT01995461

“azacitidine S.C 25 mg/m2 D1,2,3,4,5 rituximab I.V. 375 mg/m2 D8 gemcitabine I.V. 1,000 mg/m2, D8,15 dexamethasone I.V. or P.O. 40 mg D8,9,10,11 cisplatin 70 mg/m2 I.V. D8” NCT03719989

“Gemcitabine 1.0 g/m² on day 1, etoposide 60 mg/m² on days 1-3, pegaspargase 2000 IU/m² on day 4, and dexamethasone 40 mg on days 1-4, repeated every 21 days for 1 cycle.” NCT07678229

“The primary objective is to assess the efficacy and safety of Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (Dara-VRD) followed by cilta-cel in high-risk SMM.” NCT06574126

“single intratympanic injection of either 12 mg OTO-104 (otic formulation of dexamethasone in thermosensitive poloxamer) or placebo (1:1) and were observed for 3 months.” PMID 37185596 Apr 2023

“Induction: Lenalidomide 25 mg daily on Days 1-21 followed by 7 day rest and Dexamethasone 40 mg by mouth (po) daily on Days 1, 8, 15 and 22 every 28 days for 4 cycles.” NCT00691704

“Multi-agent chemotherapy including vincristine, prednisone, daunorubicin, cyclophosphamide, pegaspargase, cytarabine, 6-MP, MTX, and dexamethasone per protocol phases.” NCT07454226

Dexamethasone sodium phosphate, 0.1% ophthalmic solution will be administered 4 times daily for 4 weeks, then 2 times daily for 2 weeks, then 1 time daily for 2 weeks.” NCT06213649

“VRD:Bortezomib, Lenalidomide and Dexamethasone Bortezomib SC 1.3mg/sqm on day 1,8,15,22, Lenalidomide oral 25 mg on day 1-21, and Dexamethasone 40mg on day 1,8,15,22” NCT05870917

“Glucocorticoid (either Dexamethasone or Methyl-prednisolone) infusions will be administered on Days 1 to 3 (cycles 1-4(6)) and should precede the Rituximab infusion.” NCT01576588

“Use of a dexamethasone insert alleviates the need for postoperative steroid eye drops and may provide increased pain relief post-CXL as compared to topical therapy.” NCT04168112

“Gemox: Gemcitabine and Oxaliplatin; IGEV: Ifosfamide, Gemcitabine, Vinorelbine, and Prednisolone; DHAP: Dexamethasone, high-dose Cytarabine (Ara-C) and Cisplatin.” NCT04342936

Dexamethasone, although potentially protective against perioperative dysphagia and airway compromise, could inhibit fusion, a generally proinflammatory process.” PMID 25932600 May 2015

“Next, an anesthetic solution of Ropivacaine 0.375% (dose 37.5 mg) plus Mepivacaine 1% (dose 100 mg) and Dexamethasone 4mg, total volume 21 ml, will be injected.” NCT06155903

“This phase 1/2 dose-escalation study aimed to determine the maximum tolerated dose (MTD) of lenalidomide in combination with melphalan and dexamethasone (M-dex)” PMID 20724537 Aug 2010

“Palonosetron 0.25 mg IV + Dexamethasone 12 mg IV + Fosaprepitant 150 mg IV for early emesis and for delayed emesis Dexamethasone 8 mg orally on days 2, 3 and 4.” NCT03606369

“5-hydroxytryptamine-3 (5-HT3) antagonist (Ramosetron, Tropisetron) and dexamethasone are supplied from the first day of chemotherapy, and lasting for 3-5 days.” NCT02195908

“Steroid active group will involve two doses of dexamethasone; 25 mg given prior to starting surgery and 25 mg given on the morning of second postoperative day.” NCT02950233

“Lumbar puncture: cytarabine 50mg+dexamethasone 5mg+methotrexate 10mg, intrathecal injection, once a month after remission, a total of 4-6 courses of treatment.” NCT06861348

“Intraoperatively: Intravenous Dexamethasone 0.1mg/kg (maximum dose of 8mg), Magnesium 2g, Acetaminophen 1000mg, and local infiltration of 0.5% Ropivacaine 20ml” NCT07076069

“Group A will receive 0.07 mg/cm of 0.5% Hyperbaric Bupivacaine in conjunction with 2 mg (0.5 ml) of preservative-free Dexamethasone administered intrathecally” NCT07363941

“PD-1 monoclonal antibody is a new attempt treatment, and ruxolitinib and/or low-dose dexamethasone can reduce the inflammation that occur in EBV-HLH or CAEBV.” NCT05039580

“5-hydroxytryptamine-3 (5-HT3) antagonist (Ramosetron , Tropisetron)and dexamethasone are supplied from the first day of chemtherapy,and lasting for 3-5days.” NCT02195921

“Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone.” PMID 39866949 Jan 2025

“Methylene blue compound injection are mixed by Methylene Blue injection, Dexamethasone powder-injection, Ropivacaine injection and Normal saline injection.” NCT03200808

“Intra-arterial administration of argatroban (0.2-0.3 mg/min), dexamethasone (0.1 mg/min) and edaravone (0.3 mg/min) for 30 to 60 minutes after thrombectomy” NCT04202549

“Bortezomib-containing chemotherapy regimen (e.g. cyclophosphamide, bortezomib, and dexamethasone (CyBorD)) according to the institutional standard of care” NCT04973137

“10mg morphine + 8mg dexamethasone completed to 5 ml with normal saline + 10 ml of 0.25% bupivacaine (total volume of 15ml) were injected intra-articularly” NCT04790292

“After enrollment, patients are to receive four cycles of RAD induction treatment: a combination of lenalidomide (Revlimid), adriamycin, and dexamethasone.” NCT00925821

“Standard Chemotherapy (which includes cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, 6-mercaptopurine, etoposide, and cytarabine” NCT03319901

“The most common drug used with iontophoresis for pain caused by such things as apophysitis of the knee is dexamethasone sodium phosphate (dexamethasone).” NCT03606980

“Includes vincristine, daunorubicin, cyclophosphamide, pegaspargase, prednisone, dexamethasone, cytarabine, 6-mercaptopurine, and high-dose methotrexate.” NCT07495631

“standard of care combined with glucocorticoid(dexamethasone: 3mg qd x 5 days; or prednisone: 20mg qd x 5 days; or methylprednisolone: 16mg qd x 5 days)” NCT05855395

Dexamethasone 5mg and palonosetron 0.25mg i.v. will be given after induction, and droperidol 1.25 mg i.v. will be given during the abdominal closure.” NCT07480785

“Dextenza is a sustained-release dexamethasone intracanalicular insert recently approved by the FDA for pain and inflammation post ophthalmic surgery.” NCT04426734

“Patient will receive Dara-CyBorD (Daratumumab, Bortezomib, Cyclophosphamide, Dexamethasone) for at least 6 cycles, and then Daratumumab maintainance.” NCT06418477

“For treatment delivery, subjects will receive 60 mL of 0.25 percent ropivacaine with 4 mg of dexamethasone either at the initiation of the procedure” NCT05753046

“participants will receive the medications of Serivteronel and Dexamethasone (also known as SEVI-D) by oral tablets continuously per cycle (4 weeks).” NCT03600467

“Antihistamine, H2 receptor antagonist, acetaminophen (or equivalent), dexamethasone (or equivalent) administered per product label prior to MK-6837.” NCT06460961

“Evaluate the efficacy and safety of Belantamab Mafodotin, cyclophosphamide, and dexamethasone in patients with Relapsed/Refractory Multiple Myeloma” NCT04896658

“20mL 0.5% Bupivacaine with 5 mg PF dexamethasone and 5 mcg epinephrine (total volume 20.5mL) in single injection interscalene brachial plexus block” NCT03887650

“usual paclitaxel pre-treatment consisting of Dexamethasone, Chlorpheniramine and ranitidine, at 15 and 1 day before the actual paclitaxel treatment” NCT03301454

“mLDG (lidocaine 0.16mg/mL, dexamethasone 0.02mg/mL, and gentamycin 0.16mg/mL) dissolved in 0.9% saline solution was administered three times a day.” NCT02577393

“Patients will be randamized allocated into two groups: Group D (Ondanesterone plus dexamethasone) or Group M (ondanesterone plus metoclopramide) .” NCT06810531

“FTD regimen(fotemustine, temozolomide and dexamethasone),fotemustine 100mg/m2 d1 ivgtt,temozolomide 150mg/m2 d1-5 po,dexamethasone 40mg d1-5 ivgtt” NCT05274139

“pre-treatment with Dexamethasone will induce a persistent senescence phenotype in tumor cell sub-populations expressing moderate/high levels of GR” NCT04037462

“0.12 mg/kg/day floxuridine (FUDR) and 25 mg dexamethasone in normal saline to a total volume of 300 ml will be administered through the HAI pump.” NCT03493061

“0.12 mg/kg/day floxuridine (FUDR) and 25 mg dexamethasone in normal saline to a total volume of 300 ml will be administered through the HAI pump.” NCT03678428

“intraligamentary dexamethasone administered prior to buccal 4% articaine infiltration in mandibular molars with symptomatic irreversible pulpitis” NCT07506265

“FVD regimen(fotemustine, teniposide and dexamethasone),fotemustine 100mg/m2 d1 ivgtt,teniposide 60mg/m2 d2-4 ivgtt,dexamethasone 40mg d1-5 ivgtt.” NCT01960192

“Clinical Study of Reduced-dose Pomalidomide and Cyclophosphamide Combined With Dexamethasone in the Treatment of Patients With Debilitating RRMM” NCT06255847

“0.12 mg/kg/day floxuridine (FUDR) and 25 mg dexamethasone in normal saline to a total volume of 300 ml will be administered through the HAI pump” NCT02102789

“The patients will receive Dexamethasone 8 mg (Corodex, Laboratorio Celsius, Montevideo, Uruguay) PO 1 hour before surgery (Almeida et al 2019)” NCT05924191

“Intrathecal liposomal cytarabine combined with intrathecal prednisolone and oral dexamethasone during maintenance treatment for high-risk ALL” NCT00991744

Dexamethasone 20 mg days 1-2, 4-5, 8-9 and 11-12 during the first 2 cycles, thereafter individualized dose depending on response and toxicity” NCT00602511

“The subject's standard care regimen upon entering the study; this could consist of hydrocortisone, dexamethasone, prednisone or prednisolone.” NCT03532022

“Oral mini-pulse steroids (low-dose dexamethasone: 5mg/week on 2 successive days per week) for 4 weeks before NCES and for 4 weeks afterward.” NCT07472816

“Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients” NCT04025450

“Lumbar Transforaminal Epidural Steroid Injections was administered, consisting of 4 mg dexamethasone and 0.33% lidocaine in a 3 ml solution” NCT06656429

Dexamethasone (Soldesam 0.2%) will be supplied as 20 mg liquid for oral administration (1 bottle = 20 mg; daily dose = 2 bottles = 40 mg).” NCT00786851

“Granisetron+dexamethasone: granisetron:40mcg/kg, IV ; dexamethasone : S\<0.6m2, 2 mg/dose, q12h IV/PO; S\>0.6m2, 4 mg/dose, q12h , IV/PO.” NCT05230654

“Intervention group will receive 30 ml of a 50/50 mixture of isobaric bupivacaine 0.5% and lidocaine 1%, containing 8 mg of dexamethasone.” NCT07313553

“steroid therapy with Dexaven 4 mg / 1 ml - 2 injections at weekly intervals containing single doses of dexamethasone (total dose of 8 mg)” NCT04492774

Dexamethasone: (oral) 40mg on Day 1,8,15,22 every month for 9 months; and maintained with 20mg (oral) every two weeks from Month 9 to 21.” NCT03982771

Dexamethasone was also approved as an alternative pharmacological agent for the prevention and treatment of mild and moderate shivering.” NCT06091657

dexamethasone administered at a dose of 40 mg (or 20 mg for patients\>75 years old) on Days 1, 8, 15, and 22 of a repeated 28-day cycle.” NCT04674514

“Given that low dose dexamethasone dramatically improved the response rate of pomalidomide, this drug will be added to the combination.” NCT01889420

“P.o. cyclophosphamide 300 mg/sqm on days 1, 8 and 15 and p.o. dexamethasone 20 mg on days 1, 2, 8, 9, 15 and 16 in each 28-days series” NCT02572492

“Intravenous Dexamethasone, 8mg three times per day tapering down for 7 days Per os dexamethasone, 2mg per day tapering down for 7 days” NCT01231009

“With Intravenous Antiemetic Drugs Dexamethasone and Ondansetron and Incidence of Post-operative Nausea Vomiting for Inner Ear Surgery” NCT02724033

“CT: Oral 2-4 mg of dexamethasone twice daily for 5 days and then 2-4 mg daily for 5 days at the discretion of the treating physician” NCT05789589

“HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies” NCT07175415

“Interscalene brachial plexus blockade using plain bupivacaine with adjuvants: clonidine, epinephrine, buprenorphine, dexamethasone.” NCT03845894

“Corticosteroid in the form of dexamethasone administered as an oral (liquid or tablets) or intravenous preparation 6 mg once daily” NCT04381936

“Corticosteroid: 0.5 cc saline and 0.5cc of 10 mg/mL dexamethasone per facet joint (up to 6 mL total volume for 4 facet injections)” NCT04392999

Dexamethasone: Patients received intravenous dexamethasone 20 mg daily from days 1 to 5, reduced to 10 mg daily from days 6 to 10.” NCT05658692

“The liposome formulation of dexamethasone sodium phosphate (TLC599) was developed for the sustained relief of osteoarthritis pain.” PMID 35189943 Feb 2022

“Group II received injections of 4 mL of 2% preservative-free prilocaine combined with 2 mL or 8 mg of dexamethasone, totaling 6 mL” NCT06507995

“administration of 20 ml volume of local anesthetics (Lidocaine 2% +Bupivicaine 0.5% 1:1 mixture + 8mg dexamethasone) on each side” NCT06155097

dexamethasone 12 mg iv, ondansetron 8 mg iv before chemotherapy aprepitant 80 mg orally D2-4, dexamethasone 8 mg/day orally D2-4” NCT03876938

“Standard of care therapy can include remdesivir and/or dexamethasone per institutional treatment guidelines or written policies” NCT04351152

“High-dose dexamethasone (HD-DXM) will be administered orally (40 mg) from day 1-4, followed by Arm 1 or 2 (1:1 randomization).” NCT04812483

“GDP, gemcitabine 1000 mg/m2 on days 1 and 8, cisplatin 25 mg/m2 on days 1-3, and dexamethasone 40 mg on days 1-4 every 21 days” PMID 32349779 Apr 2020

“Maximum tolerated dose of Temsirolimus Rituximab (375 mg/m²) Dexamethasone (120 mg) Cisplatin (100mg/m²) Cytarabine (2x2g/m²))” NCT01653067

“Combination of anti acne cream that contain active substances such as Clindamycin 3%, Dexamethasone 0.05% and Tretinoin 0.05%” NCT04118296

“All patients will receive pre-surgical ocular surface treatment with intracanalicular sustained release dexamethasone, 0.4 mg” NCT04530864

“New trio combination is a drug containing 0.1% isobutylamido-thiazolyl-resorcinol, 0.1% retinoic acid and 0.1% dexamethasoneNCT07676994

“The induction therapy is a combination of Blinatumomab(Blina), Vindesine(VDS), Cyclophosphamide(CTX) and Dexamethasone(DXM).” NCT06742515

“The study intervention involves implementing a treatment bundle that includes inhaled ipratropium bromide and dexamethasone.” NCT06074185

“(dexamethasone ophthalmic insert)-for the treatment of ocular inflammation and pain following following ophthalmic surgery.” NCT05372315

“Group A: Patients who will receive transversus abdominis plane block with - 18ml Bupivacaine 0.25%+ 2 ml Dexamethasone 8mg.” NCT07590752

“block procedure will involve the use of a local anesthetic solution (10-20 ml of 0.25% bupivacaine and 2 mg dexamethasone)” NCT06298370

“About 20 patients received Ultrasound-guided (USG-TAP) block with 40 ml of 0.375% levobupivacaine plus 8ml dexamethasone.” NCT06970548

“The patient in Group I will be given caudal epidural injection with 0.25% ropivacaine 20 ml containing dexamethasone 8 mg” NCT05904275

Dexamethasone 5 mg/m2 Days 1 and 2; 10mg/m2 Day 3 to 5; Cyclophosphamide 200 mg/m2 Days 1 and 2 Intrathecal therapy Day 1” NCT04881838

“* Dexamethasone : D1\~D4 daily oral administration or intravenous injection, 40mg(or 20mg for age for age ≥ 65 years old)” NCT04298372

Dexamethasone was injected into the two side of thyroid, the dose of dexamethasone was 5 mg by every side, twice a week.” NCT00917241

“Medications used during the procedure include 0.75% bupivacaine with or without 1 mg of preservative free dexamethasone.” NCT06621329

“Comparator Ozurdex® (dexamethasone) was formulated as a rod shaped implant to be inserted into the eye by an applicator.” NCT01396057

“Parasternal block with Bupivacaine 0.25% + Epinephrine 1:200,000 x 60cc + Dexamethasone 5mg and Dexmedetomidine 50mcg” NCT05191745

“liposomal Bortezomib-Dexamethasone-Doxorubicin (PAD) alternating with Bortezomib-Dexamethasone-Cyclophosphamide (VCD)” NCT02858999

“Bendamustine 70-90mg/m2, d1, d2 Liposome Adriamycin 15-20mg/m2, d1 or Adriamycin 10mg d1-d4 Dexamethasone 40mg qw po.” NCT05006469

Dexamethasone orally at 20 mg on day of daratumumab administration (pre-daratumumab) and 20 mg on the following day.” NCT03215524

Dexamethasone 10mg+ bortezomib (1.3mg /m2 IV) was administered at D1,D4,D8,D11, one month for 1 cycle, for 2 cycles.” NCT05383547

Dexamethasone Tablets (administered on Day 1, 12 mg, once daily; administered from Day 2 to 4, 3.75 mg, twice daily)” NCT07124195

“corticosteroids such as dexamethasone, prednisone, methylprednisolone or hydrocortisone may be administered as SOC.” NCT06729593

“corticosteroids such as dexamethasone, prednisone, methylprednisolone or hydrocortisone may be administered as SOC.” NCT06729606

“corticosteroids such as dexamethasone, prednisone, methylprednisolone or hydrocortisone may be administered as SOC.” NCT04843761

“pulse dose of oral dexamethasone 2.5mg for adults for two consecutive days per week and half the dose for children” NCT06768840

“The eye will have a sustained release device of Dexamethasone 0.4 mg placed in the inferior nasal lacrimal system.” NCT04563559

“prednisone/prednisolone 5 mg twice daily orally or dexamethasone 0.5 mg once daily for 12 cycles (28 days/cycle).” NCT00600535

“powder included dexamethasone, diphenhydramine, tetracycline, metronidazole, nystatin, zinc oxide, and karaya gum” NCT02142543

“Patients will use the preservative-free dexamethasone 0.1% 4 times a day in the first week after cataract surgery” NCT04050644

“regimen B is a combination therapy regimen : anlotinib combined with pomalidomide or dalattoumab + dexamethasone.” NCT05549973

Dexamethasone, a high-potency, long-acting glucocorticoid, has been shown to prolong peripheral nerve blockade .” NCT04838379

“If the weekly dose of dexamethasone is 40mg, it should be taken in the first two days of the week, 20mg per day;” NCT05802992

“treatment with either prednisone or dexamethasone as palliative therapy for the control of neurological symptoms” NCT04461418

“1 weeks' treatment with nasal tramazoline and dexamethasone compared with 1 weeks' treatment with nasal placebo.” PMID 23397296 Feb 2013

“R-GDP:rituximab 375mg/m\^2 Day 1 (or Day 8), gemcitabine 1g/m\^2 on Days 1 and 8, dexamethasone 40mg on Days 1-4” NCT03391466

“infiltration injection of 0.7 ml of dexamethasone lateral to the involved tooth after anesthesia administration.” NCT06457828

“After induction, 0.5mg/kg of dexamethasone and an IV infusion of 15mg/kg of acetaminophen will be administered.” NCT03467750

“Recommendations for the management of COVID-19 pneumonia will be followed, including the use of dexamethasone.” NCT04808882

Dexamethasone (10mg/d) (Days1-3) Tropisetron (4mg or 4.48mg or 5mg /d) (Days1-3) Olanzapine (10mg/d) (Days1-4)” NCT03571126

“Patients of this group will receive 25 mg bupivacaine 0.5%, plus 8 mg dexamethasone in a total volume of 10 ml” NCT04656821

Dexamethasone and/or vincristine and/or pegasparaginase OR cytarabine and/or etoposide and/or pegasparaginase” NCT03236857

“or a bioequivalent dose of oral corticosteroids (e.g., 1,250mg prednisone daily or 176mg dexamethasone daily)” NCT07100990

“Randomized to dexamethasone ophthalmic insert 0.4mg placed prior to cataract surgery, on the day of surgery.” NCT05023304

“Study of Dexamethasone-Allantoin-Metronidazole (DAM) Solution in the Treatment of Post-Operative Ileus (POI)” NCT01863407

“8 mg dexamethasone was applied into the tibio-femoral joint with a 22-gauge, 10 cm needle under fluoroscopy.” NCT06017674

“Patients undergo induction therapy with 6 cycles of daratumumab, bortezomib, lenalidomide and dexamethasoneNCT05231629

“This insert allows for sustained release of dexamethasone onto the ocular surface over a period of 28 days.” NCT06235567

“CVAD is the acronym of the drugs in course a: cyclophosphamide, vincristine, doxorubicin and dexamethasone.” NCT05581030

“5-HT3 Receptor Antagonist, NK1 Receptor Antagonist, Dexamethasone administered orally, IV, or transdermally” NCT07169851

“Patients will receive adjuvant dexmedetomidine (25mcg) and dexamethasone (5mg) in addition to bupivacaine.” NCT06658054

“Dose group 1 received 114ug of dexamethasone, Dose group 2 received 513ug and Dose group 3 received 684ug.” NCT01048593

“early use of dexamethasone/Methylprednisolone as early as laboratory evidence of high inflammatory markers” NCT04530409

“30 mL of 0.25% bupivacaine + 0.5 mL (5 mg) preservative-free dexamethasone + 0.1 mL epinephrine 1:400,000.” NCT05996133

“Vincristine 0.5 mg/d d 1 - 4 CI Adriamycin 10 mg/m2/d d 1 - 4 CI Dexamethasone 40 mg/d d 1-4, 9-12, 17-20” NCT00580372

“Effect of pre-medication with anti-inflammatory drugs(ibuprofen and dexamethasone)on Post-Endodontic pain” NCT06980870

“patients in group( SD )will receive 8-mg dexamethasone IV in 500-mL normal saline after spinal anesthesia” NCT04778189

Dexamethasone 10mg or Depomedrol 40mg, together with Bupivacaine 0.25% (for 3-5mL total injectate volume)” NCT02103543

“Patients will receive a single intraoperative dose of 10mg of intravenous dexamethasone intraoperatively.” NCT04738318

“The injectate in the active arm will contain a combination of bupivacaine, epinephrine and dexamethasone.” NCT04019834

“Low-dose lenalidomide continuous SC infusion (STAR-LDD) in combination with bortezomib and dexamethasoneNCT06087653

“FST-100 (PVP-I 0.4% and dexamethasone 0.1%). A regimen of 2 drops 4 times a day while awake for 5 days.” NCT00941486

“One dose of Dexamethasone (20mg/day) followed by prednisone 1mg/kg/day with a maximum dose of 60mg/day.” NCT00953303

Dexamethasone improves the quality and duration of peripheral nerve block over local anaesthetic alone.” NCT04551833

“Pemetrexed 15 mg was administered with dexamethasone 5 mg via intraventricular or via lumbar puncture.” NCT06296745

“Intrathecal chemotherapy with 40mg of pemetrexed and 2mg of dexamethasone, every 3 weeks as one cycle.” NCT07304739

“standard care which includes ketorolac, bupivacaine, fentanyl, ondansetron, dexamethasone, sevoflurane” NCT01868425

“A 6ml solution of 4ml 0.25% Bupivacaine, 1ml 40mg Kenalog, and 1ml 4mg Dexamethasone will be prepared.” NCT01688362

“In group A, the investigators used combined Lidocaine 2% and dexamethasone (8mg/2ml) with ratio (1:1).” NCT03265197

“Paracetamol, Vitamin D, Oxygen if indicated, Low molecular weight heparin, dexamethasone if indicated” NCT04523831

“prednisolone/prednisone 5 mg taken orally twice daily or dexamethasone 0.5 mg taken orally once daily” NCT01664728

Dexamethasone is a potent and highly selective glucocorticoid with minimal mineralocorticoid effect.” NCT04715152

“During treatment, participants receive dexamethasone 20 mg orally 12 to 6 hours prior to paclitaxel;” NCT01953536

“Initial Cytoreduction is performed with DHAP- protocol using dexamethasone, cytarabine and cisplatin” NCT00384553

Dexamethasone was given 20 mg orally on days 1, 8, 15 and 22, limited to the two first cycles only.” PMID 39909655 Feb 2025

“Intravenous ceftriaxone with either oral methyl prednisolone or intravenous dexamethasone was given” NCT04935515

“Bupivacaine, Dexamethasone, Epinephrine for hernia patients receiving abdominal wall reconstruction” NCT07518238

dexamethasone ((Dexaven 4mg/ml, Jelfa, Poland) in a dose of 4 mg will be administered intravenously” NCT06609993

“Intravenous analgesia with ketoprofen, dipyrone and dexamethasone. IV morphine to rescue analgesia” NCT02239497

“A single DEXTENZA® releases a 0.4 mg dose of dexamethasone for up to 30 days following insertion.” NCT04529512

Dexamethasone (4mg ampoule, intravenous) Dose: 6mg intravenous every day for a maximum of 10 days” NCT04536363

“Experimental: Drug:Fosrolapitant and Palonosetron for injection Drug:Dexamethasone Drug: placebo” NCT07692451

“An intravenous injection of 8 mg of Dexamethasone is added to prolong the duration of the block.” NCT03984656

“Corticosteroid agent used is either Dexamethasone 8 mg or Triamcinolone acetonide 0.3-0.6 mg/kg” NCT07713329

dexamethasone 8mg, methylprednisolone 80mg and bupivacaine 5ml 0.25%, intra articular injection” NCT07489521

“A single intravenous 20 mg dose of dexamethasone will be applied one hour before starting dose.” NCT06886074

“gelatin sponge sheet covered with thrombin and tobramycin and dexamethasone ophthalmic ointment” NCT06175676

“OFA (n=159) consisting of intravenous ketamine, dexamethasone, lidocaine, and magnesium sulfate” PMID 42190101 May 2026

“The ALLR3 chemotherapy regimen (vincristine, mitoxantrone, dexamethasone, and PEG-asparaginase” NCT05748171

“NETILDEX™ (Netilmicin Sulfate 3mg/ml / Dexamethasone Disodium Phosphate 1mg/ml) ophthalmic gel” NCT02973880

“high dose dexamethasone : 40mg/day , D1-D4, D9-D12, IV or PO, repeat every 21days for 2cycles” NCT01255514

“Patients will receive 20 ml 0.25% bupivacaine plus 4 mg dexamethasone on each side TAB bock.” NCT05323565

“P (Prednisone): 60 mg/m²/day (max 100 mg/day) or equivalent dexamethasone dose on days 1-14.” NCT06930105

“Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone (Hyper-CVAD)” NCT01184885

“All participants receive dexamethasone (given orally at a dose of 40 mg per day for 4 days)” NCT02834468

“single injection,5ul solution,concentration: 103.4 μg/μl, equivalent to 517μg dexamethasoneNCT06497699

Dexamethasone is a corticosteroid that is similar to a natural hormone made by your body.” NCT01440582

“premedication of Dexamethasone, Paracetamol, Vimovo; postoperative Paracetamol and Vimovo” NCT02604446

Dexamethasone sodium phosphate is fluoromethyl prednisolone, a synthetic glucocorticoid.” NCT05999955

“The Effect of Dexamethasone in Full Pulpotomy on Postoperative Pain in Permanent Molars” NCT07233577

“intracanalicular dexamethasone (0.4mg) insert compared to standard steroid drop regimen” NCT04281862

“Dextenza is a 0.4mg dexamethasone ophthalmic insert manufactured by Ocular Therapeutix.” NCT05587231

“cyclophosphamide 500mg D1-8-15 + thalidomide 100-200mg D1-28 + dexamethasone 40mg/week” NCT03792620

“bortezomib along with dexamethasone and pegylated liposomal doxorubicin (Doxil/Caelyx)” NCT00570180

“Initiation : cyclosporine 3mg/kg p.o.bid + dexamethasone 10mg/m2/d po. or i.v. (D1-3)” NCT01547143

dexamethasone 8mg intramuscular every 12hours for 48 hours i.e. in four divided doses” NCT03473210

“group D will receive Inj Bupivicain plus Dexamethasone in Erector Spinae Plane Block.” NCT05277974

“Fludarabine 40mg/m2 po.d1-3; Adriamycin 50mg/m2 i.v.d1; Dexamethasone 20mg/d po.d1-5.” NCT00840385

“Drug: Dexamethasone, Dexamethasone (20mg, iv, on days 1-4, 8-11of each 28 day cycle)” NCT01852799

“Brentuximab Vedotin Etoposide Cyclophosphamide Doxorubicin Dacarbacine DexamethasoneNCT06919679

“Group B : will receive bupivacaine 0.25% +dexamethasone (8 mg), total volume(20 ml)” NCT06294665

“oral dexamethasone 7.5mg pretreatment 12h, 3h, 1h before each infusion of docetaxel” NCT06306612

Dexamethasone 4 mg evening before, morning of and evening of each dose of docetaxel” NCT00541099

Dexamethasone 8mg orally twice a day for 6 doses (starting on the morning of day 2)” NCT04075955

Dexamethasone 0.013 mg/kg fat-free mass daily taken orally for a total of 21 days.” NCT00805207

“Clemastine fumarate 1,0 mg/g + dexamethasone 0,5/g applied 2 times / day at lesion” NCT01257061

“Ropivacaine 0.5% total dose 3mg/kg with Dexamethasone 8mg/20 ml Ropivacaine 0.5%.” NCT04338984

“2 to 4 cycles of IV P-DHAP (pembrolizumab, dexamethasone, cytarabine, cisplatin)” NCT04838652

“Take orally (cetirizine 10 mg bid, dexamethasone 8 mg bid, ranitidine 150 mg bid” NCT05922358

“Daratumumab in combination with Gemcitabine, Dexamethasone and Cisplatin (D-GDP)” NCT04251065

“5ul dexamethasone, concentration: 103.4 μg/μl, equivalent to 517μg dexamethasone” NCT06429306

Dexamethasone 20(20-40) mg PO/IV daily for 5 consecutive days, every 14 - 28 day” NCT00117598

“Id: Ixazomib 4mg po d1,8,15; Dexamethasone 20mg po d1,8,15,22; (28 days /cycle).” NCT05477797

“DexaEDO (dexamethasone) eyedrops without preservatives are applied additionally.” NCT01228149

“following the use of intravitreal dexamethasone implant for the treatment of DME” NCT04038125

Dexamethasone 10 mg/m2/day IV 1 - 5 days, Methotrexate 1000 mg/m2 12 h IV 1 day” NCT02842931

“Cyclophosphamide + Doxorubicin + Vincristine + Dexamethasone (DXM)] ± Rituximab” NCT06520163

Dexamethasone IV on the day of surgery (Day 0) with tapered doses through Day 4” NCT02130817

“salvage chemotherapy with intravenous dexamethasone/cisplatin/cytarabine (DHAP)” NCT00003143

“Enoxaparin, dexamethasone, and antibiotics if associated bacteremia is present” NCT04475991

“tobramycin/dexamethasone (TobraDex ST ; 'ST') ophthalmic suspension 0.3%/0.05%” PMID 21138337 Dec 2010

“2ml(4mg/ml) of dexamethasone administered two hours prior to Mw administration” NCT01424735

“Eltrombopag Oral Tablet 25-75 mg daily for 12 weeks plus pulsed dexamethasoneNCT03830749

“magic mouthwash (diphenhydramine, dexamethasone and nystatin) plus sucralfate” NCT00814359

“Patients received a single intravitreal injection with 340 µg dexamethasone.” PMID 36542081 Oct 2022

“Bupivacaine 0.25% + Lidocaine 1% + dexamethasone 4 mg + epinephrine 5 mcg/ml” NCT05834023

“All patients received 8 mg dexamethasone and lidocaine at a dose of 1 mg/kg.” NCT06958913

“fixed-dose MAD (Methotrexate, L-asparaginase and Dexamethasone) chemotherapy” NCT03246750

Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate - Lab. Union Chemical” NCT01227863

“Oral or parenteral corticosteroid (e.g., dexamethasone, methylprednisolone)” NCT05819541

“treatment with 700 microg or 350 microg of dexamethasone DDS or observation” PMID 20212197 Mar 2010

“methotrexate (15 mg/m 2 ), cytarabine (40 mg/m 2 ) and dexamethasone (4 mg)” NCT02396043

“Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide” NCT01160484

Dexamethasone 40mg PO or IV at D1-4 (dose diminution at 20 mg for Age ≥65y)” NCT03599960

“DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use” NCT05620901

“with or without intratympanic dexamethasone 5 mg/ml injection for 2-4 times” NCT06467526

“one month of topical G. Dexamethasone 0.1% with Neomycin sulphate 3500IU/g” NCT00789971

Dexamethasone 10 mg (dose blinded) in 50 ml D5W IVPB over 15 minutes daily” NCT00781768

“treated with daratumumab, bortezomib, cyclophosphamide, and dexamethasone.” NCT06771180

Dexamethasone 40 mg/p.o. days 1-4 and 9-12 cycles 1-4 (Cycles of 21 days)” NCT01084837

“Premedication/Precautions: Dexamethasone 4mg IV, Diphenhydramine 25 mg IV” NCT05768919

“Ropivacaine and Adrenalin, systemic Ketorolac and high dose DexamethasoneNCT02374008

“* Dexamethasone 200 mg Intravenous Infusion "Piggy-Back" (IVPB) Days 1-7” NCT00577512

“combination with dexamethasone given orally as a 20 mg daily for 4 days” NCT00229203

“200 mL Ringer solution+1mg dexamethasone after finishing the irrigation” NCT01958879

dexamethasone 8mg for anti-inflammatory and antiemetic before operation” NCT05577962

“the patients will be given 4mg dexamethasone and or 4mg ondansetron IV.” NCT02288923

“Single preoperative 0.1 mg/kg dose dexamethasone has a combined action” NCT04238377

Dexamethasone given orally only on days 1, 8, 15, and 22 of each cycle” NCT06158412

“Dextenza (dexamethasone) 0.4mg intracanalicular insert delivery system” NCT04687800

“glucocorticosteroid (prednisone, dexamethasone or methylprednisolone)” NCT02188368

Dexamethasone 20 mg/m2 P.O. or I.V. (divided BID) - D1-D5 and D15-D19” NCT06034561

“SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension” NCT03004924

“Ciprodex (0.3% Ciprofloxacin and Dexamethasone 0.1% Otic Suspension)” NCT01359098

Dexamethasone: 0.3mg/kg per dose for 3 days (minimum weight 20 kgs )” NCT01326494

Dexamethasone: 20 mg/d, orally on days 1, 2, 4, 5, 8, 9, 11, and 12.” NCT06246162

“Epidural analgesia with lidocaine 2%, 1.5 ml, and Dexamethasone 8 mg” NCT04108546

Dexamethasone will be given as pills to be taken for 4 days in a row” NCT00836173

“0.1% dexamethasone and 0.6% polyvinylpyrrolidone iodine (PVP-Iodine)” NCT01470664

“hCRF ; open-label dexamethasone that the patient is currently taking” NCT00088166

“One arm will receive one capsule of 6 mg of dexamethasone for 7 days” PMID 41005772 Sep 2025

Dexamethasone 3mg/m2/dose (max 8 mg/dose) PO BID on Days 7, 8, and 9” NCT05634369

“Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg” NCT04549935

“preservative-free dexamethasone (DEX), diclofenac (DICLO) eye drops” PMID 36602718 Jan 2023

“103.4 mcg/mcl dexamethasone: equivalent dexamethasone dose: 517 mcg” NCT05550350

“103.4 mcg/mcl dexamethasone: equivalent dexamethasone dose: 517 mcg” NCT05550363

Dexamethasone (8 mg, orally, 12/3/1 hour before docetaxel infusion)” NCT07172685

“HAIP will be filled with mixture of Floxuridine and Dexamethasone.” NCT03366155

Dexamethasone (D): 10 mg/m2 IV over 15 minutes on Day 1 and Day 2” NCT01858922

“2 ml of dexamethasone will be administered in an 8 mg/2 ml ampoule” NCT06788158

“local injection at surgical site of 40 mg\\ dose of dexamethasoneNCT06307106

Dexamethasone is a potent synthetic member of the corticosteroid.” NCT01277731

“Preservative free dexamethasone 0.1% (Monopex) drops for one week” NCT05433428

Dexamethasone: 20mg/day oral route on days 1, 8, 15, 22 per cycle” NCT02244125

“intravenous ondansetron 8 mg, and intravenous dexamethasone 12 mg” NCT06007586

dexamethasone only or in combination with any other glucorticoid” NCT02716818

“PIFB with bupivacaine, epinephrine, clonidine, and dexamethasoneNCT05676814

“Patients will receive dexamethasone (8 mg i.v.) after induction.” NCT05481970

“patients given intraoperative dexamethasone after hernia removal” NCT07411326

dexamethasone p.o. (by mouth) (days 1, 2, 4, 5, 8, 9, 11 and 12)” NCT00872521

Dexamethasone 12 mg on Day 1 and 8 mg daily from Day 2 to Day 4” NCT03831633

“IRd chemotherapy with ixazomib, lenalidomide, and dexamethasoneNCT04405167

“PO Dexamethasone (included with benzocaine in local anesthesia)” NCT03738904

“Intracanalicular sustained release dexamethasone insert 0.4 mg” NCT04464629

Dexamethasone eye drop, 1 drop, qid, for 3 days before surgery” NCT01824927

“Maxidex (0.1% Dexamethasone) 1 drop in each eye 2 times daily” NCT00631358

“Corticosteroids (methylprednisolone/dexamethasone/prednisone)” NCT04380818

“Cyclophosphamide 300 mg x1; dexamethasone x 7; vincristine x1” NCT05253495

“Corticosteroids (Dexamethasone), Anticoagulants (LMW heparin)” NCT05413642

“Duloxetine and Dexamethasone for Improving Postoperative Pain” NCT03250494

Dexamethasone: 20 mg IV or PO Days 1, 2, 8, 9, 15, 16, 22, 23” NCT07601100

Dexamethasone (DEX): 10 mg/m2 bolus days 1 and 2 IV, 8 to 11” NCT01366898

“R-DHAP (Rituximab , Dexamethasone, Ara-C, Cisplatine, G-CSF)” NCT02858258

“oral dexamethasone (20 mg po at day-1, day-4, day-8, day-11)” NCT02201576

“Solanum Night Cream (Clindamisin + Retinoid + Dexamethasone)” NCT07504822

dexamethasone - 40 mg on days 1, 2, 3, and 4 of dosing cycle” NCT00823719

“Tapering dose of dexamethasone or prednisolone upto 8 weeks” NCT05917340

dexamethasone 20 mg on days 1-4, administered intravenously” NCT03392714

“Methotrexate 12.5mg IT, Ara-C 40mg IT, Dexamethasone 4mg IT” NCT01679860

Dexamethasone: administrated once weekly every 28day cycles” NCT03150316

Dexamethasone 0.6 mg/kg/day or Methylprednisone 1 mg/kg/day” NCT01631916

dexamethasone (D, 20 mg) is given intravenously on days 1-4” NCT07604987

“OTX-DED (dexamethasone intracanalicular ophthalmic insert)” NCT05814757

“OTX-DED (dexamethasone intracanalicular ophthalmic insert)” NCT04747977

Dexamethasone (D) (maximum period of treatment= 24 cycles)” NCT03891355

dexamethasone (40 mg orally on days 1, 8, 15, and 22; KCd)” PMID 36529145 Dec 2022

“the use of 3-day dexamethasone (DEX) is often recommended” PMID 32735029 Aug 2020

“Drug:dexamethasone 40mg/d,d1-4,d11-14, IV, in cycle 2,4,6” NCT02042690

dexamethasone 8 mg (2 ml) mixed with the local anesthetic” NCT00519584

dexamethasone (20mg/d orally on days 1-4 and days 11-14)” NCT02404571

dexamethasone: 40mg (20mg for ≥75yr) on day 1, 8, 15, 22” NCT07348393

“GDP (gemcitabine, cisplatin, dexamethasone) chemotherapy” NCT02276248

“Intracanalicular Dexamethasone ophthalmic insert (0.4mg)” NCT05116345

“Blinatumomab, Dasatinib, Methotrexate, and DexamethasoneNCT06773936

dexamethasone 15mg/m2 intravenously on days 1 through 5” NCT06255795

“Cyclophosphamide,Liposome doxorubicin and DexamethasoneNCT02336386

“Change of prednisone 5mg/12h to dexamethasone 0.5mg/24h” NCT02928432

“5 ml of normal saline containing 8 mg of dexamethasoneNCT06166108

“-4mg dexamethasone, 1mg haloperidol, scopolamine patch” NCT04081545

“tobramycin 0.3% + dexamethasone 1% - União Química Lab” NCT01227915

“Single intratympanic injection of 12 mg dexamethasoneNCT03664674

“Part A: cyclophosphamide, vincristine, dexamethasoneNCT07294677

“Solumedrol, dexamethasone,prednisolone, azithromycin” NCT04871633

“4. dexamethasone 20mg on day 1-4, intravenous drip.” NCT06314334

Dexamethasone 4mg and Ondansetron 4mg intravenously” NCT01511627

“Betamethasone, dexamethasone, or methylprednisolone” NCT05401812

“oral dexamethasone (40 mg on days 1, 8, 15, and 22)” NCT04991103

“Cycles 5-8: every month Dexamethasone: 40 mg weekly” NCT04288765

“Magnesium sulphate 2.5-5g and Dexamethasone 8-16mg” NCT05172739

“rituximab + dexamethasone + cytarabine + cisplatin” NCT02055924

dexamethasone 40 mg PO or IV day1\~4 every 3 weeks” NCT02445404

“15cc 0.25% of Bupivacaine + Dexamethasone 8 mg 2cc” NCT07049835

“Pre-op dexamethasone 4mg IV and midazolam 1-2mg IV” NCT03448068

“Magnesium sulphate 2.5-5g and Dexamethasone 8-16mg” NCT04894864

“12 mg dexamethasone administered intratympanically” NCT02997189

Dexamethasone will be given by mouth on Days 1-4.” NCT05852717

Dexamethasone 9 mg/m²/day, intravenous, days 1-7.” NCT07564453

“One (1) IBE-814 IVT Implant (70 μg Dexamethasone)” NCT04576689

“Dextenza (Dexamethasone Ophthalmic Insert 0.4 mg)” NCT04563299

“single dose of dexamethasone (8mg) will injected” NCT01896427

“Bortezomib and Dexamethasone according to label.” NCT03136653

Dexamethasone 40 mg/m 2 days 1-4, 9-12 and 17-20” NCT00560053

“SMO1 (Dexamethasone 700μg intravitreal implant)” NCT07708142

“Humanized mAb targeting CD47 plus dexamethasoneNCT04445701

“Premedication includes 20 mg of dexamethasone.” NCT06977594

“Drug: Dexamethasone(40mg, orally, on days 1-4)” NCT01868828

“intracanalicular dexamethasone (0.4mg) insert” NCT04839549

Dexamethasone 40/20 mg p.o., day 1, 8, 15, 22” NCT01701076

“sustained release dexamethasone 0.4 mg insert” NCT04592081

“Oral dexamethasone + Standard premedications” NCT07469488

“* Dexamethasone 4-8 mg for PONV prophylaxis,” NCT07337135

Dexamethasone will be mixed with bupivacaine” NCT01756573

“magnesium, dexamethasone and dexmedetomidine” NCT04747171

“DPACE: dexamethasone 20 mg days 1-4 and 8-11” NCT00670631

“with dexamethasone 12 mg administered orally” NCT03386617

“1. dexamethasone :40mg/day D1-4, intravenous” NCT04065308

“PO or IV dexamethasone 40mg D1, 8, 15 and 22” NCT03143049

Dexamethasone 20 mg PO days 1, 4, 8, and 11” NCT00581919

Dexamethasone 40mg/d po or iv on D1-4, 8-11” NCT01370434

“MVD: Methotrexate,Vincristine,DexamethasoneNCT01083342

“5mg (0.5mL) preservative free dexamethasoneNCT05224089

dexamethasone 10mg intravenously on days1-3” NCT07000617

“Pre \& Post medication Dexamethasone 8mg PO” NCT00313872

“ISV-305 (0.1% Dexamethasone in DuraSite® 2)” NCT03192150

“ISV-305 (0.1% Dexamethasone in DuraSite® 2)” NCT03192137

Dexamethasone: 40 mg/day (PO/IV, Days 1-4).” NCT07059156

Dexamethasone 40 mg day 1-4 of every cycles” NCT02374424

“Bortezomib, Lenalidomide and DexamethasoneNCT05860036

“Bortezomib, Lenalidomide and DexamethasoneNCT05850286

Dexamethasone and antiemetic premedication” NCT00216138

dexamethasone 40 mg on Days 1, 2, 3, and 4” NCT01453205

“Bortezomib, Lenalidomide and DexamethasoneNCT05979363

“D, Dexamethasone oral: 40mg (days 1 to 4)” NCT04348006

dexamethasone at doses of 4 - 20 mg / day” NCT05187793

Dexamethasone: 20-40mg, po, d1,d8,d15,d22” NCT03908138

Dexamethasone, 4 mg I.V. (Intraoperative)” NCT04110587

“biodegradable 0.7mg dexamethasone implant” NCT01701518

Dexamethasone 10 mg/m2/day IV 1 - 5 days” NCT03479918

Dexamethasone, 40mg/d IV, day 1 to day 4” NCT02733458

Dexamethasone, 40mg/d iv, day 1 to day 4” NCT02764281

Dexamethasone 40 mg/day IV or PO on D1-4” NCT05966233

dexamethasone 40 mg p.o. or i.v. d 15-19” NCT00517894

Dexamethasone : 40 mg/j, days 1, 8 et 14” NCT01206205

“equivalent dose of dexamethasone at 15mg” NCT06486337

dexamethasone 12 mg po D1, 8 mg po D2-4” NCT01536691

“OZURDEX® Implant 700 µg (Dexamethasone)” NCT03908307

“sustained released dexamethasone, 0.4mg” NCT04863742

“a moderate amount of dexamethasone i/v” NCT04461925

“Ketamine 0.5 mg/kg; Dexamethasone 8 mg” NCT07414706

dexamethasone 6 mg PO every other day” NCT01302392

“Lenalidomide (Revlimid)/DexamethasoneNCT01711671

dexamethasone(6mg, oral, day 1-day 5)” NCT04536558

dexamethasone 20mg/ m2,VD d2,d3,d4,d5” NCT01933282

“Intracameral Dexamethasone (Dexycu™)” NCT04781335

dexamethasone 20mg/m2 iv on days 3-6” NCT02560441

“Adjunction of dexamethasone (HD DXM)” NCT00777738

Dexamethasone, Cytarabine, Cisplatin” NCT01453504

Dexamethasone: low dose for 10 days” NCT07711964

Dexamethasone 5 mg/m2/dose on Day 1” NCT05827549

dexamethasone (total dose 30 mg/m2)” NCT04499573

Dexamethasone intravitreal implant” NCT04856397

“DXM(dexamethasone),40mg/d,p.o,d1-4” NCT02520219

Dexamethasone 40 mg/d i.v. (d1-3)” NCT02531841

Dexamethasone 40mg D1-4 oral/I.V.” NCT06255704

Dexamethasone 40mg D1-4 oral/I.V.” NCT04736914

Dexamethasone: Orally once weekly” NCT05651932

dexamethasone(DXM) 10 mg days 1-8” NCT02520479

dexamethasone 8 mg will be added.” NCT05624957

Dexamethasone 10mg should be used” NCT05561699

dexamethasone 40 mg IVD on day 2” NCT01457144

“or sub-Tenon dexamethasone depot” PMID 34383010 Oct 2021

“Corticosteroids (Dexamethasone)” NCT05249790

Dexamethasone, 40mg, p.o. d2-d4” NCT06069830

Dexamethasone 20mg iv.drip d1-4” NCT04624958

dexamethasone 10mg ivgtt d2-6.” NCT05809180

dexamethasone 20 mg days 1 - 4” NCT03154918

dexamethasone 40 mg on Day 1-4” NCT01626664

Dexamethasone 40 mg PO weekly.” NCT03601624

“12 mg OTO-104 (dexamethasone)” NCT02265393

Dexamethasone 6mg Po QD, D1-7” NCT05244577

dexamethasone 40mg,po/iv d1-4” NCT06062641

“5mg / week oral dexamethasoneNCT05706636

“Day 1: Dexamethasone 20 mg PO” NCT05099471

“B :dexamethasone (DECTANCYL)” NCT02552251

“ISV-305 (0.1% Dexamethasone)” NCT01543490

Dexamethasone 10mg,ivg, d1-4” NCT03105596

“* Dexamethasone * Rituximab” NCT00801580

Dexamethasone 40 mg day 1-4” NCT01805557

dexamethasone 40mg, iv D1-4” NCT03373019

Dexamethasone 40 mg PO 1-4” NCT00113919

Dexamethasone (DECADRON®)” NCT00538733

Dexamethasone (Decadron®)” NCT02128230

Dexamethasone 40mg, d1-4” NCT04134247

dexamethasone 40mg D1-4” NCT05244642

Dexamethasone: 4-8mg IV” NCT07558226

Dexamethasone (DXM ) :” NCT02036489

dexamethasone 4 mg tid” NCT07584525

dexamethasone (oral)” NCT03181126

“Drug: DexamethasoneNCT03763370

“Drug: DexamethasoneNCT00247416

“Drug: DexamethasoneNCT03206671

“Drug: DexamethasoneNCT07442890

Dexamethasone 0.4mg” NCT05626478

DEXAMETHASONE 8 mg” NCT02884440

dexamethasone 8mg” NCT03518463

“8mg DexamethasoneNCT07568938

dexamethasoneNCT05246631

DexamethasoneNCT04348006

DexamethasoneNCT06172257

DexamethasoneNCT01672736

DexamethasoneNCT03837873

DexamethasoneNCT00734877

DexamethasoneNCT01575925

dexamethasoneNCT01606735

DexamethasoneNCT03335098

dexamethasoneNCT02872597

NCT00790842

NCT02709889

NCT03841565

NCT03488225

NCT04834375

NCT02862327

NCT02862145

NCT04835129

NCT06269900

NCT00989781

NCT03657420

NCT05896228

NCT00581776

NCT04832880

NCT03219710

NCT06268704

NCT04941937

NCT06879379

NCT07357597

NCT02158702

NCT05895838

NCT02046070

NCT04346654

NCT03487133

NCT06272383

NCT04828525

NCT00944502

NCT02283775

NCT06128369

NCT01749969

NCT03110562

NCT07474909

NCT02405364

NCT00293384

NCT05180097

NCT02436707

NCT03763162

NCT01078441

NCT00293592

NCT00227682

NCT00182663

NCT04826822

NCT01078454

NCT03220113

NCT00792142

NCT07353801

NCT01811251

NCT04940338

NCT06974604

NCT06974669

NCT03194594

NCT05016076

NCT01078974

NCT03486548

NCT06266481

NCT02352558

NCT04836780

NCT00290823

NCT04230330

NCT00707083

NCT04826237

NCT06722118

NCT05183139

NCT07353593

NCT01522872

NCT01748942

NCT02508402

NCT00792948

NCT02005575

NCT06968559

NCT00005834

NCT00548483

NCT00793052

NCT06968507

NCT03092817

NCT00001842

NCT02635828

NCT02416388

NCT07691684

NCT02936427

NCT02902965

NCT05016947

NCT04836962

NCT01523314

NCT00793663

NCT04351737

NCT00738621

NCT02548962

NCT05186454

NCT03847792

NCT03289299

NCT00942201

NCT03199482

NCT02004275

NCT05172908

NCT02665533

NCT07694089

NCT04822337

NCT01370408

NCT00793923

NCT02547662

NCT03109691

NCT01363817

NCT01748487

NCT01080391

NCT06731101

NCT00584168

NCT05900882

NCT04352205

NCT05887778

NCT05887765

NCT01363479

NCT01524731

NCT02195479

NCT07698080

NCT06979596

NCT00179647

NCT01363128

NCT01525069

NCT04353505

NCT00000563

NCT02087527

NCT02104778

NCT06715709

NCT02295709

NCT06131593

NCT02436694

NCT02003222

NCT02416869

NCT05190705

NCT05190952

NCT04345588

NCT05191706

NCT07699315

NCT01474915

NCT06980727

NCT02547623

NCT07479979

NCT07699744

NCT00290511

NCT05192889

NCT05018091

NCT00290498

NCT00794976

NCT04355039

NCT02416934

NCT02506660

NCT04818749

NCT04975997

NCT01361789

NCT04818372

NCT02937571

NCT00290433

NCT04166565

NCT06981754

NCT06878599

NCT00489307

NCT03314181

NCT06121843

NCT01518465

NCT04817982

NCT03839940

NCT06713733

NCT05195242

NCT02169882

NCT06132685

NCT07469332

NCT02002598

NCT01526694

NCT04817189

NCT03556332

NCT00016302

NCT04344730

NCT03287908

NCT02037399

NCT01527032

NCT02550119

NCT01527149

NCT01083316

NCT00580112

NCT04816097

NCT02863991

NCT05170789

NCT02858804

NCT02047253

NCT01083420

NCT05199311

NCT01359657

NCT02938468

NCT00482261

NCT00945646

NCT03760835

NCT03314636

NCT02406144

NCT04813653

NCT06133712

NCT00992355

NCT01812057

NCT02436265

NCT01083602

NCT01371630

NCT02939183

NCT00016380

NCT04939142

NCT06119893

NCT02773030

NCT07343817

NCT00215748

NCT01442428

NCT07345819

NCT01745640

NCT00299182

NCT00176462

NCT01745588

NCT02339740

NCT01084252

NCT02095834

NCT01358253

NCT07343128

NCT02086942

NCT01358201

NCT02550795

NCT00176293

NCT00176280

NCT00945802

NCT02404220

NCT07482891

NCT00004403

NCT02198235

NCT02857465

NCT05205252

NCT03057015

NCT06118710

NCT07709000

NCT06988124

NCT06288035

NCT06988488

NCT01839487

NCT02551133

NCT03481556

NCT07362914

NCT01356511

NCT02864602

NCT04360876

NCT03658590

NCT03180736

NCT07709884

NCT02903381

NCT05208307

NCT07341867

NCT07341854

NCT03562169

NCT03480607

NCT00016887

NCT06289673

NCT00579501

NCT00588835

NCT04162210

NCT05872893

NCT03695744

NCT01355705

NCT03856112

NCT02856438

NCT01459211

NCT06992128

NCT07485127

NCT03856502

NCT06704139

NCT02193698

NCT01072773

NCT03480308

NCT05871073

NCT04840615

NCT06824467

NCT01531998

NCT02159365

NCT01743755

NCT00302003

NCT05216055

NCT02406222

NCT04841018

NCT03555929

NCT04802356

NCT01532856

NCT03177317

NCT04161248

NCT01372904

NCT07677215

NCT05020236

NCT00017069

NCT04973605

NCT02106494

NCT00479089

NCT03859102

NCT01088022

NCT02633059

NCT03051022

NCT04799015

NCT00478777

NCT02355678

NCT04798391

NCT02773602

NCT02199665

NCT03193788

NCT07676396

NCT01534169

NCT02903680

NCT03478605

NCT00478218

NCT00799227

NCT00169572

NCT01846390

NCT07486544

NCT01999335

NCT02440880

NCT02718833

NCT03859427

NCT00477971

NCT03859024

NCT02257476

NCT03860038

NCT00579020

NCT01088763

NCT00578955

NCT07335887

NCT03518112

NCT06259006

NCT06300099

NCT05861297

NCT01846611

NCT03860844

NCT01998971

NCT00477412

NCT00491127

NCT02765854

NCT06997081

NCT02719613

NCT03290950

NCT07334379

NCT01090089

NCT00934739

NCT06997419

NCT03692754

NCT02154048

NCT00476593

NCT01348919

NCT06694077

NCT00168389

NCT01090180

NCT07674576

NCT00168337

NCT00168324

NCT03697356

NCT04368598

NCT07332936

NCT00168298

NCT04976777

NCT04176718

NCT05857982

NCT02441686

NCT00476190

NCT02403037

NCT00215943

NCT04791566

NCT02441894

NCT06136598

NCT06304324

NCT00592566

NCT04791345

NCT00708292

NCT01807286

NCT07330999

NCT00014209

NCT02659293

NCT06304909

NCT02106988

NCT06999070

NCT06136624

NCT01998503

NCT06136650

NCT01091831

NCT00801138

NCT03361709

NCT00186875

NCT04790474

NCT01346787

NCT03759093

NCT04371445

NCT01997840

NCT01754402

NCT04156828

NCT00305812

NCT05232825

NCT03863977

NCT01537861

NCT01374217

NCT04788654

NCT01538459

NCT02553460

NCT03218553

NCT02850601

NCT00549848

NCT01739985

NCT03564704

NCT00475085

NCT03763734

NCT01812720

NCT04843579

NCT05023369

NCT05235256

NCT07329933

NCT04156581

NCT04786964

NCT03114865

NCT02720510

NCT05850143

NCT04225611

NCT01539083

NCT01093196

NCT00166439

NCT02933099

NCT05236621

NCT01070862

NCT00017602

NCT04341155

NCT01344174

NCT02085655

NCT03283917

NCT02631239

NCT05909826

NCT05848687

NCT00995501

NCT04784559

NCT00802009

NCT00227019

NCT00288080

NCT00474188

NCT07672873

NCT04783194

NCT02096835

NCT07002216

NCT05023915

NCT01737931

NCT04782687

NCT02884180

NCT07327931

NCT01094990

NCT06685991

NCT00473746

NCT07327216

NCT00187005

NCT00244855

NCT00165178

NCT01541332

NCT00473512

NCT02153060

NCT00005945

NCT03652064

NCT00308477

NCT05911321

NCT01736917

NCT02402725

NCT00308542

NCT00004228

NCT02665936

NCT00213226

NCT03283046

NCT00308594

NCT04155008

NCT05841121

NCT03227432

NCT05024344

NCT02402543

NCT04780581

NCT01813227

NCT02192827

NCT06137924

NCT07324499

NCT03311425

NCT02036502

NCT03763760

NCT00471640

NCT05242874

NCT04779060

NCT00244153

NCT06683924

NCT01341262

NCT01849783

NCT00492284

NCT02510157

NCT03554473

NCT03871049

NCT06682637

NCT02535806

NCT02723994

NCT07671066

NCT03871829

NCT06317662

NCT06886230

NCT04380857

NCT07368075

NCT01543945

NCT02847494

NCT06106945

NCT01734928

NCT04776850

NCT05246631

NCT02904538

NCT01850524

NCT03679065

NCT04776395

NCT00598169

NCT01477762

NCT02336815

NCT01339260

NCT07463807

NCT01734161

NCT04240054

NCT05248633

NCT01734057

NCT04775550

NCT01734044

NCT04151667

NCT04933539

NCT02368301

NCT01545700

NCT00928486

NCT07493486

NCT04150965

NCT05250973

NCT02883049

NCT05027594

NCT03117140

NCT01337752

NCT01478048

NCT01546402

NCT00928200

NCT03758170

NCT03492138

NCT07315373

NCT03117751

NCT02528123

NCT06679101

NCT02945527

NCT00187057

NCT07494136

NCT00805649

NCT02846493

NCT03757715

NCT04771026

NCT03117361

NCT02401529

NCT03094442

NCT03651128

NCT06104449

NCT00693433

NCT02011113

NCT04150614

NCT03567369

NCT00187070

NCT03567473

NCT03567616

NCT03874936

NCT01335399

NCT03366584

NCT00492999

NCT03173092

NCT01548573

NCT05028348

NCT05257083

NCT00577668

NCT03472573

NCT00187083

NCT01731886

NCT03876574

NCT01376297

NCT07668700

NCT02415413

NCT01731795

NCT03698630

NCT01102426

NCT00021359

NCT04847453

NCT02725008

NCT04767256

NCT04178512

NCT07014462

NCT03367156

NCT05259839

NCT00806819

NCT02343042

NCT02628704

NCT00022126

NCT01549431

NCT00004778

NCT01103401

NCT05158699

NCT06102447

NCT04766853

NCT03877549

NCT05825378

NCT01376427

NCT00600353

NCT05028907

NCT07015021

NCT05824832

NCT02726308

NCT03172988

NCT01550146

NCT00807521

NCT00022737

NCT01332812

NCT04765371

NCT03367572

NCT01478581

NCT01104025

NCT04764942

NCT01332630

NCT03836014

NCT06819748

NCT00807599

NCT02109081

NCT04243109

NCT06888817

NCT04848259

NCT06140966

NCT04223661

NCT00314743

NCT02294357

NCT02203253

NCT02726581

NCT04148846

NCT01991158

NCT00023530

NCT07498998

NCT01478737

NCT06832254

NCT02419118

NCT02947672

NCT02845882

NCT04763434

NCT00187122

NCT01990781

NCT00285389

NCT01331590

NCT02597062

NCT04762745

NCT05821192

NCT02556424

NCT03107182

NCT07018050

NCT04762381

NCT02192320

NCT06819436

NCT00024167

NCT07665762

NCT05820763

NCT00004785

NCT02056379

NCT03756896

NCT02089113

NCT05918796

NCT06959407

NCT06330519

NCT01329289

NCT02179892

NCT02203643

NCT01553214

NCT00689936

NCT00601172

NCT01553357

NCT02335983

NCT07019545

NCT00316927

NCT07503184

NCT01328236

NCT03094663

NCT06331520

NCT03317847

NCT05271058

NCT05271539

NCT03171974

NCT06099366

NCT02844907

NCT01554852

NCT05271721

NCT04147806

NCT02526199

NCT03834506

NCT00025259

NCT01989325

NCT06142396

NCT05272826

NCT07305987

NCT02556814

NCT04392037

NCT02280993

NCT03833947

NCT00156299

NCT06818981

NCT00317408

NCT01555281

NCT07665450

NCT04392648

NCT04756726

NCT02348528

NCT01756586

NCT04756401

NCT01728259

NCT05274113

NCT02626481

NCT01326585

NCT00025636

NCT07023120

NCT04393207

NCT02056717

NCT00005977

NCT06658834

NCT02672527

NCT04754945

NCT04930211

NCT07024043

NCT00026234

NCT05032183

NCT01556438

NCT02445326

NCT04394481

NCT06742138

NCT04244695

NCT03773107

NCT03349281

NCT03043495

NCT02557035

NCT02204241

NCT01107951

NCT07025005

NCT00464685

NCT04395105

NCT02525848

NCT01108133

NCT02894645

NCT02776436

NCT01324180

NCT04752852

NCT01109004

NCT06817551

NCT02334813

NCT04752163

NCT02253784

NCT02906332

NCT05279391

NCT02419469

NCT03570645

NCT02400437

NCT04751877

NCT00687674

NCT04751175

NCT05008367

NCT00283985

NCT02045017

NCT05280275

NCT04850885

NCT02109861

NCT02433899

NCT03571321

NCT06653699

NCT02843074

NCT01110135

NCT00319865

NCT04397354

NCT00152867

NCT01559935

NCT02160301

NCT06336395

NCT00687011

NCT04397458

NCT07027540

NCT02445872

NCT04747912

NCT00152620

NCT05284409

NCT01434017

NCT04246047

NCT01066429

NCT07662200

NCT02497378

NCT03041948

NCT04981093

NCT00248547

NCT00686855

NCT05285813

NCT02951117

NCT04747080

NCT00711555

NCT05286008

NCT04746430

NCT06956170

NCT02625181

NCT03572686

NCT01001091

NCT03041935

NCT04945824

NCT06953960

NCT05286814

NCT05287035

NCT02666209

NCT00028886

NCT05922501

NCT01319981

NCT00734929

NCT00005985

NCT00813150

NCT02525718

NCT04144933

NCT02951377

NCT05288062

NCT02253316

NCT04743661

NCT00462787

NCT02545907

NCT01724892

NCT03319667

NCT01985477

NCT03348696

NCT05289492

NCT03700177

NCT05805800

NCT00005987

NCT01318902

NCT05289908

NCT02951819

NCT00711828

NCT03467256

NCT00711841

NCT01562405

NCT02952573

NCT03231215

NCT03170882

NCT03646916

NCT01111851

NCT03778008

NCT05036577

NCT00030069

NCT05804032

NCT02624856

NCT06339151

NCT00461747

NCT02110719

NCT07301138

NCT03889743

NCT02532192

NCT05292664

NCT04970719

NCT03204760

NCT03371589

NCT00603447

NCT05293210

NCT00151203

NCT07032714

NCT04853147

NCT07508202

NCT05293509

NCT02400242

NCT01316770

NCT01432600

NCT00538824

NCT03795571

NCT04403516

NCT02400047

NCT02732015

NCT01065272

NCT00150462

NCT02496299

NCT01114048

NCT04853446

NCT00814541

NCT03040011

NCT01002248

NCT06342466

NCT00538733

NCT00002471

NCT03795909

NCT02881086

NCT07299877

NCT04405375

NCT00920153

NCT01983969

NCT03683277

NCT02733380

NCT03553238

NCT01722305

NCT02953210

NCT00324467

NCT03515200

NCT00784927

NCT00576251

NCT05798195

NCT02495922

NCT06645678

NCT02252419

NCT00033332

NCT01564537

NCT04737980

NCT02399657

NCT02559154

NCT04407442

NCT07509866

NCT03232307

NCT07036237

NCT05298683

NCT07297329

NCT02206425

NCT06643689

NCT01481194

NCT00740415

NCT01116193

NCT04925193

NCT02084134

NCT03292926

NCT01116713

NCT00188864

NCT01720875

NCT04982809

NCT00000658

NCT00002481

NCT05147493

NCT00148018

NCT02623426

NCT03465540

NCT05302388

NCT02057380

NCT01983449

NCT02252172

NCT05793060

NCT04947189

NCT00005998

NCT05303311

NCT03892421

NCT04221087

NCT02206503

NCT01312818

NCT00458822

NCT02840539

NCT02103335

NCT00458705

NCT01117441

NCT03892434

NCT02735317

NCT05791721

NCT03576547

NCT01856062

NCT05303792

NCT03202628

NCT00148317

NCT00209495

NCT00952133

NCT00784745

NCT01311687

NCT04181827

NCT00250718

NCT01481519

NCT04924647

NCT00002494

NCT06348108

NCT05305404

NCT01311167

NCT05789303

NCT01381692

NCT04411329

NCT00250926

NCT05145543

NCT05145400

NCT04411693

NCT06348147

NCT05306340

NCT02111785

NCT02181218

NCT00002499

NCT00006002

NCT00457678

NCT01310101

NCT02494882

NCT05308654

NCT00216736

NCT06892522

NCT02057640

NCT05787574

NCT00817479

NCT02102815

NCT02419755

NCT07513129

NCT02735707

NCT01309451

NCT01568866

NCT04729114

NCT01431014

NCT02145715

NCT02736175

NCT04412694

NCT06635629

NCT00750633

NCT00002514

NCT04728646

NCT02867046

NCT04412707

NCT01569204

NCT06086431

NCT02779283

NCT01511211

NCT07455396

NCT06086418

NCT00818259

NCT00209222

NCT04413253

NCT06086392

NCT01119287

NCT03578081

NCT04413279

NCT02034019

NCT02349763

NCT01004497

NCT02332850

NCT06953440

NCT00952341

NCT03527576

NCT01569919

NCT05316168

NCT00002517

NCT02837614

NCT07652879

NCT00012051

NCT02420210

NCT01980589

NCT00918190

NCT01759706

NCT00763763

NCT03896737

NCT03374085

NCT01570387

NCT04414475

NCT06811675

NCT06350565

NCT07378215

NCT06085417

NCT00038090

NCT03036605

NCT07294118

NCT00005777

NCT04140162

NCT02513186

NCT04923893

NCT00038610

NCT05319730

NCT05143762

NCT02408068

NCT03898154

NCT04726098

NCT02955810

NCT02955823

NCT00144963

NCT05143281

NCT07380139

NCT01979536

NCT04330690

NCT01571232

NCT03643822

NCT06894069

NCT03374514

NCT02703272

NCT06351644

NCT00039130

NCT00002531

NCT01857115

NCT01979276

NCT03035942

NCT02655523

NCT02372240

NCT02593669

NCT01572480

NCT02739035

NCT03061812

NCT07052201

NCT06629818

NCT03035929

NCT00002532

NCT01857232

NCT00331084

NCT03643666

NCT00330824

NCT05142098

NCT06810531

NCT06353022

NCT03183596

NCT06083922

NCT05325593

NCT06951087

NCT07052864

NCT02279394

NCT04251715

NCT02928029

NCT03900624

NCT04182997

NCT06353386

NCT06627751

NCT03643276

NCT07290595

NCT02619019

NCT04418999

NCT01005758

NCT02780479

NCT06747975

NCT00607581

NCT01062568

NCT06809855

NCT03035214

NCT03168100

NCT06082934

NCT01122511

NCT00750815

NCT07651150

NCT05932524

NCT00002548

NCT01303003

NCT01383759

NCT03901768

NCT01383928

NCT02780609

NCT00040937

NCT02112864

NCT01816620

NCT00953420

NCT06152575

NCT01005914

NCT02112916

NCT01510613

NCT00679367

NCT05776940

NCT03701321

NCT00000689

NCT03902249

NCT04717700

NCT00041132

NCT04136743

NCT00821249

NCT07289620

NCT01797991

NCT06356415

NCT04329650

NCT05331690

NCT06356571

NCT00915408

NCT03902782

NCT00608101

NCT06624436

NCT03829371

NCT03765541

NCT03376672

NCT00333814

NCT05774028

NCT00333996

NCT06241547

NCT05773664

NCT07649525

NCT01816971

NCT01714427

NCT04423367

NCT07287826

NCT03034733

NCT02492750

NCT02420717

NCT03234972

NCT00733083

NCT04133636

NCT02958514

NCT01797822

NCT01859702

NCT05334316

NCT02741388

NCT02642380

NCT04329325

NCT07056244

NCT02523976

NCT02190760

NCT04714112

NCT01976195

NCT02372812

NCT00452569

NCT00334672

NCT00011362

NCT03033511

NCT06622005

NCT05139043

NCT02303821

NCT03276325

NCT00608907

NCT01125761

NCT03702725

NCT02891811

NCT03033316

NCT06080880

NCT01712789

NCT05138029

NCT01298076

NCT06080724

NCT00574080

NCT07285239

NCT00783367

NCT00335140

NCT01578343

NCT01975727

NCT00609518

NCT00452062

NCT00000703

NCT01297764

NCT04711213

NCT03104842

NCT07452198

NCT01297686

NCT00335348

NCT03661645

NCT04131309

NCT07523295

NCT03215030

NCT07284758

NCT04709185

NCT04709029

NCT04708821

NCT01297010

NCT01007500

NCT03641508

NCT00609765

NCT05343156

NCT01975285

NCT01483690

NCT04984330

NCT03084783

NCT03641456

NCT00335920

NCT00609817

NCT01296503

NCT03582033

NCT02491632

NCT03033199

NCT03166761

NCT04130802

NCT03121534

NCT01580020

NCT00451594

NCT07060859

NCT02562417

NCT03751059

NCT05137080

NCT02353468

NCT04707534

NCT06361329

NCT03906617

NCT04129697

NCT02616640

NCT07061678

NCT04430361

NCT02744508

NCT00253318

NCT01428492

NCT06616792

NCT02491411

NCT04858776

NCT04184999

NCT01295112

NCT01834820

NCT00553059

NCT01711528

NCT02834286

NCT02834260

NCT01862315

NCT05346731

NCT05936086

NCT03828292

NCT06616597

NCT00764907

NCT02909478

NCT06616584

NCT03798678

NCT00981708

NCT01581151

NCT00049374

NCT05347381

NCT03457142

NCT06750458

NCT06616220

NCT03308084

NCT00337506

NCT01294319

NCT00825071

NCT03675555

NCT06616142

NCT05136560

NCT02353572

NCT00337727

NCT03456752

NCT02767219

NCT05936528

NCT01861340

NCT06615479

NCT04919317

NCT02082405

NCT04430894

NCT05761730

NCT04327401

NCT02293109

NCT07064889

NCT00825864

NCT07064993

NCT07065968

NCT07525934

NCT03583255

NCT02880228

NCT00137995

NCT01864018

NCT04860518

NCT04432012

NCT04432259

NCT00573391

NCT03539744

NCT04126278

NCT04126200

NCT04950049

NCT03909412

NCT02891798

NCT03236792

NCT04432597

NCT03031730

NCT00050414

NCT02615262

NCT06945263

NCT01583283

NCT02278315

NCT07068230

NCT03165825

NCT04700176

NCT02374060

NCT06074263

NCT00050440

NCT00732446

NCT05355610

NCT02514382

NCT01863550

NCT02833116

NCT06948084

NCT06752317

NCT03122756

NCT02961816

NCT02654990

NCT00343369

NCT07450638

NCT02304250

NCT03705273

NCT04217148

NCT07450508

NCT00137111

NCT02450968

NCT04124497

NCT02450994

NCT01427751

NCT03030261

NCT06367855

NCT00343460

NCT02783144

NCT04123873

NCT05359731

NCT02348216

NCT02114502

NCT00674141

NCT04437017

NCT04917406

NCT00343863

NCT05049473

NCT04917250

NCT04917055

NCT03275285

NCT00532961

NCT01009931

NCT04697745

NCT02698995

NCT00136435

NCT00344422

NCT03165123

NCT00447577

NCT00344526

NCT03323047

NCT07528118

NCT00054158

NCT05752305

NCT03705507

NCT00136084

NCT00910897

NCT00054522

NCT06806410

NCT04440267

NCT01706666

NCT05751187

NCT01586806

NCT00135811

NCT03639610

NCT03324113

NCT05132920

NCT01133158

NCT01971658

NCT07072234

NCT01971645

NCT02101944

NCT05751044

NCT03029234

NCT04120519

NCT03104270

NCT02963493

NCT01133743

NCT07386600

NCT04694105

NCT02749162

NCT06376721

NCT04442022

NCT02189343

NCT04119336

NCT01010243

NCT05367271

NCT00000723

NCT00010231

NCT04862468

NCT00135187

NCT05369364

NCT00056160

NCT07073209

NCT07275593

NCT07643103

NCT07275320

NCT02831686

NCT04862585

NCT06158841

NCT01134484

NCT06604286

NCT01485835

NCT05050305

NCT04915248

NCT06942884

NCT04690647

NCT01588925

NCT06603662

NCT00445692

NCT03914625

NCT03520985

NCT07072585

NCT05745714

NCT02265510

NCT04325061

NCT00909077

NCT00057564

NCT00532155

NCT05372354

NCT00613457

NCT03296189

NCT01284478

NCT02612779

NCT03028012

NCT05943691

NCT01867710

NCT02362165

NCT07387926

NCT02784340

NCT01135550

NCT03825198

NCT03237533

NCT00276809

NCT02698306

NCT03237611

NCT00572169

NCT07074691

NCT03450057

NCT07388069

NCT01455389

NCT04116398

NCT00671658

NCT03512353

NCT06160180

NCT01868269

NCT04216524

NCT04115956

NCT02750670

NCT02305173

NCT04447027

NCT07639723

NCT02248870

NCT06598059

NCT00059930

NCT00908232

NCT00781300

NCT01969565

NCT01868633

NCT06233617

NCT01794520

NCT00060398

NCT01794507

NCT05129085

NCT02965196

NCT00671034

NCT07077850

NCT02644694

NCT05945797

NCT07078786

NCT06233565

NCT07388602

NCT02644720

NCT04448496

NCT00060684

NCT00060944

NCT02751593

NCT05738486

NCT06160791

NCT03296358

NCT02682134

NCT06232707

NCT04113018

NCT04112823

NCT01138839

NCT01592370

NCT01057225

NCT00907452

NCT00832234

NCT00832338

NCT07082270

NCT04681105

NCT05736419

NCT05385523

NCT00531453

NCT05736081

NCT06382948

NCT07081256

NCT00061945

NCT03382821

NCT03125941

NCT03746652

NCT00669877

NCT02666443

NCT02248428

NCT01794039

NCT01593410

NCT00531284

NCT00002665

NCT03239314

NCT01277289

NCT06383572

NCT04452565

NCT01277159

NCT05052970

NCT07084285

NCT02031965

NCT01277016

NCT01390012

NCT06590402

NCT07638527

NCT07084441

NCT07084753

NCT03239964

NCT00956462

NCT00501826

NCT04323280

NCT05732883

NCT00833560

NCT01702233

NCT00131261

NCT05732532

NCT00002676

NCT00906503

NCT02966522

NCT00131053

NCT00131027

NCT04912427

NCT00833833

NCT04912271

NCT01594749

NCT06232044

NCT05392946

NCT01275664

NCT02753166

NCT07538375

NCT05731960

NCT01012336

NCT02828358

NCT07085728

NCT02654132

NCT04188431

NCT03446937

NCT07086118

NCT00441168

NCT00002678

NCT07636564

NCT01275014

NCT05730036

NCT06387121

NCT02292082

NCT00130195

NCT00205751

NCT02079649

NCT01464034

NCT00064038

NCT00616603

NCT02362321

NCT00440726

NCT01056276

NCT02697383

NCT02375555

NCT04911361

NCT00064337

NCT02697344

NCT03240783

NCT05397236

NCT01273727

NCT00905034

NCT01273493

NCT02967276

NCT06387823

NCT02116530

NCT01143129

NCT00002689

NCT00002691

NCT05727163

NCT04103684

NCT01965626

NCT02101853

NCT01700946

NCT00065611

NCT02589145

NCT07088146

NCT01013012

NCT02351804

NCT03924791

NCT03161938

NCT03674294

NCT01424982

NCT01464112

NCT02215980

NCT05124067

NCT04910568

NCT03023878

NCT06389617

NCT06233604

NCT03589222

NCT00903968

NCT07540728

NCT03589326

NCT05405166

NCT01965353

NCT02216071

NCT03064633

NCT03081416

NCT00002700

NCT00835965

NCT01832727

NCT04910503

NCT07444710

NCT00530270

NCT02763059

NCT00275509

NCT06390319

NCT01270932

NCT03023527

NCT04909918

NCT00617591

NCT04461028

NCT02266433

NCT06230224

NCT04189107

NCT06900777

NCT01055496

NCT02188537

NCT01792102

NCT07542288

NCT05123131

NCT03160729

NCT02544425

NCT04667663

NCT01699412

NCT07088432

NCT04667507

NCT05721027

NCT02544308

NCT05720949

NCT03530683

NCT07258498

NCT03200600

NCT01876290

NCT03927313

NCT01391793

NCT00439296

NCT06759584

NCT00002704

NCT00003783

NCT00127764

NCT06163898

NCT00438841

NCT00438828

NCT02787018

NCT01698918

NCT00438672

NCT05719701

NCT04096066

NCT07543458

NCT01055301

NCT01698801

NCT06577025

NCT04463953

NCT01698788

NCT05004753

NCT07257406

NCT02767882

NCT01698749

NCT00902915

NCT04094961

NCT02266797

NCT00002716

NCT01962792

NCT03590652

NCT01698281

NCT00003753

NCT03443778

NCT02969837

NCT00275106

NCT01267084

NCT02825186

NCT04908592

NCT05717374

NCT01266811

NCT04094805

NCT06863259

NCT00555100

NCT02484911

NCT00718640

NCT04465864

NCT03931135

NCT05716945

NCT02825147

NCT06901817

NCT03745105

NCT06575010

NCT04663555

NCT04663347

NCT03822182

NCT04663269

NCT02588417

NCT02896582

NCT07095452

NCT01488279

NCT00437229

NCT05714839

NCT03021772

NCT02217163

NCT00275015

NCT04319978

NCT01697098

NCT05711823

NCT03242460

NCT06574048

NCT04091126

NCT03710603

NCT07254416

NCT05422027

NCT00619359

NCT01602224

NCT03710772

NCT05120076

NCT04089605

NCT03634852

NCT07391657

NCT03440411

NCT07096778

NCT07097493

NCT01881789

NCT01149616

NCT00718757

NCT04661137

NCT00003728

NCT00002744

NCT03934684

NCT01882127

NCT02971982

NCT03591744

NCT03158688

NCT00072514

NCT02351622

NCT01054144

NCT03387956

NCT06846255

NCT03673826

NCT00274820

NCT01790685

NCT04474223

NCT03711474

NCT01470196

NCT01603498

NCT07099222

NCT07631910

NCT03439293

NCT03439280

NCT04658927

NCT01422733

NCT03937635

NCT06762769

NCT03270033

NCT04474938

NCT02061631

NCT00124579

NCT00005603

NCT07247097

NCT02090790

NCT03341676

NCT01261546

NCT05704049

NCT04265534

NCT00569920

NCT03020030

NCT00256776

NCT04347980

NCT06569251

NCT00074191

NCT00074178

NCT04476979

NCT01470131

NCT07246070

NCT05060627

NCT05432414

NCT03512223

NCT00433537

NCT06404541

NCT00000776

NCT04317872

NCT02569320

NCT00075725

NCT01154192

NCT02877303

NCT05432934

NCT02137395

NCT00075829

NCT05434689

NCT04907227

NCT03742297

NCT05435547

NCT07628166

NCT03269136

NCT00555906

NCT03713294

NCT00008294

NCT07101445

NCT04655144

NCT06846073

NCT05438043

NCT04083066

NCT04654507

NCT01885481

NCT00005601

NCT00274430

NCT01605942

NCT00003671

NCT00122785

NCT02137161

NCT03389620

NCT04653246

NCT01393964

NCT04191616

NCT05439798

NCT01692197

NCT02431286

NCT00504751

NCT04479748

NCT00621985

NCT05695508

NCT03942224

NCT05441761

NCT03942601

NCT03940469

NCT04650893

NCT01421810

NCT00663169

NCT06050512

NCT00122278

NCT03595514

NCT06169215

NCT04989140

NCT07104097

NCT01394354

NCT01691690

NCT00002785

NCT02219178

NCT03742115

NCT04873284

NCT01155583

NCT07548736

NCT01421797

NCT01953978

NCT04266977

NCT01256580

NCT04649060

NCT03436225

NCT00003663

NCT04648358

NCT04082962

NCT00895245

NCT01887587

NCT01256398

NCT02482129

NCT06408974

NCT00556127

NCT05692245

NCT00895076

NCT05062681

NCT00002788

NCT06409702

NCT02136134

NCT04212845

NCT06561854

NCT00366106

NCT01156883

NCT00843310

NCT04316936

NCT01255358

NCT01690663

NCT02532634

NCT00431990

NCT06222723

NCT01052038

NCT05690984

NCT00366834

NCT06410443

NCT01789242

NCT03500445

NCT02393859

NCT03948035

NCT04483739

NCT00002798

NCT02344732

NCT02046915

NCT00238225

NCT03435003

NCT02219581

NCT06559553

NCT04267913

NCT03390387

NCT02275702

NCT07109258

NCT00078949

NCT07624513

NCT00003650

NCT00257634

NCT04484623

NCT02062905

NCT05688475

NCT01689987

NCT02135874

NCT05687981

NCT00431236

NCT05451771

NCT03785184

NCT00003639

NCT03769818

NCT06413498

NCT01788475

NCT03155100

NCT01421186

NCT01490060

NCT00080444

NCT06932562

NCT03950674

NCT07550803

NCT04643002

NCT01159574

NCT02431208

NCT03130348

NCT00430118

NCT00892996

NCT04268498

NCT00623766

NCT05681260

NCT04488081

NCT02912702

NCT03017391

NCT05455320

NCT05679765

NCT04965155

NCT05002361

NCT02243124

NCT00002812

NCT06416891

NCT03952091

NCT01490437

NCT03434340

NCT00008242

NCT00258245

NCT06556095

NCT02030483

NCT00273377

NCT04640168

NCT04075227

NCT00891761

NCT01788020

NCT05675319

NCT02586038

NCT05456542

NCT01951066

NCT03066544

NCT01686386

NCT01787669

NCT00083538

NCT00003603

NCT01162746

NCT00083551

NCT03531970

NCT00526305

NCT03328975

NCT00083681

NCT00368121

NCT00083460

NCT06554626

NCT02076009

NCT01891643

NCT03201965

NCT06554184

NCT06044480

NCT00083902

NCT02921893

NCT05459571

NCT00083915

NCT00005596

NCT04313959

NCT03542617

NCT03740659

NCT06904599

NCT03079453

NCT00193869

NCT04638790

NCT01612702

NCT02410382

NCT01250808

NCT01396083

NCT00427999

NCT04875039

NCT03953807

NCT01250717

NCT03715478

NCT00754949

NCT00846703

NCT03015792

NCT00000801

NCT02585531

NCT01049945

NCT00084864

NCT02119468

NCT02977494

NCT05669989

NCT01249690

NCT06043336

NCT00370760

NCT00119002

NCT01165021

NCT04270175

NCT04498468

NCT00890552

NCT00720109

NCT03630367

NCT03079219

NCT04270409

NCT06042725

NCT04636671

NCT00002816

NCT03685032

NCT04499313

NCT06042426

NCT06793475

NCT01248923

NCT00084708

NCT05668455

NCT05066997

NCT01248585

NCT04068597

NCT04067609

NCT05667324

NCT03132454

NCT00426101

NCT00507416

NCT04501367

NCT00507442

NCT00006232

NCT02479620

NCT02479555

NCT03394820

NCT00004990

NCT04635189

NCT05665140

NCT02605356

NCT04899414

NCT00201812

NCT04635176

NCT02653144

NCT04066647

NCT04066426

NCT07228052

NCT04898920

NCT07227311

NCT05466604

NCT06216158

NCT05663866

NCT06428630

NCT07554963

NCT03956966

NCT01680796

NCT03432949

NCT01168531

NCT03740334

NCT03957499

NCT06172257

NCT02290470

NCT00372294

NCT02914054

NCT07402707

NCT07555938

NCT05972135

NCT01615029

NCT04065789

NCT03954379

NCT02819024

NCT00006240

NCT00201695

NCT02818985

NCT04272775

NCT01168804

NCT02020941

NCT07227584

NCT04503668

NCT03959085

NCT03688269

NCT02980835

NCT06906315

NCT01246557

NCT01616173

NCT06930690

NCT05469893

NCT07556952

NCT00525447

NCT01169415

NCT01246063

NCT00888303

NCT03432650

NCT00507858

NCT07438119

NCT05660473

NCT06930651

NCT05470530

NCT04273282

NCT00776802

NCT06173466

NCT06429982

NCT03960151

NCT06039280

NCT07617246

NCT04504825

NCT00201643

NCT02818491

NCT02021240

NCT00557193

NCT02290431

NCT01170780

NCT00627393

NCT00849251

NCT00002849

NCT03598426

NCT01679093

NCT05658640

NCT01397552

NCT02516423

NCT03247413

NCT00424047

NCT07404709

NCT01492400

NCT04063189

NCT02460055

NCT04507412

NCT01946477

NCT05476770

NCT00656656

NCT07559331

NCT00657410

NCT00524589

NCT00375791

NCT02478047

NCT01946152

NCT06432712

NCT05000658

NCT01502085

NCT00116961

NCT00005585

NCT01945866

NCT03012880

NCT03664037

NCT05656521

NCT03338400

NCT04508400

NCT06790732

NCT04508790

NCT01677858

NCT00006250

NCT07615595

NCT04877275

NCT07560449

NCT05478993

NCT05655130

NCT02584452

NCT03151811

NCT07224672

NCT02685826

NCT01022528

NCT05654649

NCT05479578

NCT02793011

NCT03523221

NCT06433947

NCT01172912

NCT03626922

NCT04509973

NCT07224334

NCT07614802

NCT05070247

NCT02793843

NCT01769209

NCT00002865

NCT03396107

NCT04624360

NCT03133897

NCT02686151

NCT00087815

NCT03739528

NCT02382068

NCT01897714

NCT05070468

NCT03011905

NCT02382146

NCT04209218

NCT06537518

NCT02121262

NCT04061512

NCT04060771

NCT07614360

NCT06536491

NCT05974501

NCT04896658

NCT01241006

NCT02760459

NCT06437054

NCT00002878

NCT03805932

NCT02983097

NCT07436546

NCT05484648

NCT02817347

NCT06535256

NCT07222761

NCT04999878

NCT00378105

NCT00378209

NCT02794441

NCT03719105

NCT01023308

NCT04308837

NCT04512235

NCT06212336

NCT02760043

NCT05975294

NCT02477215

NCT00003493

NCT04513184

NCT03330028

NCT05647512

NCT05647408

NCT02871193

NCT01239797

NCT05486481

NCT00629473

NCT04276090

NCT01900509

NCT00420849

NCT04513639

NCT01239719

NCT02021851

NCT06210750

NCT04514029

NCT00378547

NCT02410694

NCT05487508

NCT06533748

NCT05645718

NCT00089167

NCT02692248

NCT05105997

NCT04895592

NCT01673191

NCT01673087

NCT02073734

NCT01046461

NCT05488847

NCT03969875

NCT06176235

NCT03720041

NCT00089453

NCT02516696

NCT01024075

NCT00884546

NCT06789367

NCT04054193

NCT01672736

NCT02424045

NCT06789328

NCT00630565

NCT04619303

NCT05072262

NCT00853008

NCT01237951

NCT02816905

NCT03010202

NCT01769820

NCT02322242

NCT05641324

NCT02223598

NCT03136146

NCT05491304

NCT03970655

NCT04895410

NCT03687931

NCT01501370

NCT03398044

NCT00418353

NCT01237249

NCT01046006

NCT02186834

NCT04052880

NCT06208917

NCT07216820

NCT01415882

NCT04879823

NCT03150693

NCT00003449

NCT04050865

NCT01236586

NCT04519385

NCT01501149

NCT05493618

NCT01045876

NCT02985333

NCT07609706

NCT02690922

NCT04051723

NCT07134075

NCT01903720

NCT00113607

NCT05495035

NCT02985840

NCT02517021

NCT02224170

NCT05638087

NCT02461888

NCT00381680

NCT06789042

NCT01903811

NCT02176213

NCT04277845

NCT05496764

NCT06789029

NCT03767920

NCT02815319

NCT01045681

NCT05497804

NCT00003423

NCT01670097

NCT05977998

NCT01670084

NCT03817320

NCT04963816

NCT05498220

NCT01415583

NCT00381862

NCT02986451

NCT02462148

NCT00416897

NCT06208150

NCT01669499

NCT00775411

NCT00003437

NCT00090909

NCT00112879

NCT05635227

NCT04610398

NCT02237820

NCT00522392

NCT03399539

NCT04278833

NCT00564889

NCT02542657

NCT03101579

NCT03263520

NCT06527976

NCT04208516

NCT00091260

NCT03623087

NCT07567274

NCT04524455

NCT00261612

NCT01668719

NCT00558519

NCT03078062

NCT03601871

NCT07608731

NCT00007358

NCT00770562

NCT02224729

NCT07432399

NCT07213375

NCT02462525

NCT05631405

NCT00003416

NCT02987907

NCT01414569

NCT06207305

NCT04047446

NCT00415064

NCT07138209

NCT07210047

NCT04527770

NCT02767713

NCT05100186

NCT04527887

NCT06924424

NCT06207123

NCT04607447

NCT01500226

NCT07208799

NCT02648490

NCT02987985

NCT01500213

NCT07208253

NCT04606264

NCT07607691

NCT02813135

NCT04528329

NCT00006345

NCT01449344

NCT00510887

NCT02520115

NCT03401372

NCT07139522

NCT05509374

NCT00564603

NCT01666210

NCT04045795

NCT02755597

NCT00558896

NCT02100657

NCT05509634

NCT02529774

NCT01782963

NCT00003402

NCT04882163

NCT01230593

NCT00111748

NCT02574468

NCT04998786

NCT01665794

NCT00003401

NCT06787196

NCT05981209

NCT01402284

NCT01938729

NCT03815279

NCT04530565

NCT00003399

NCT04603911

NCT07204041

NCT03544281

NCT00003397

NCT03069950

NCT03669445

NCT00880191

NCT04043494

NCT03402295

NCT07569757

NCT07569952

NCT04603729

NCT02988882

NCT03007927

NCT01632150

NCT07570173

NCT00111072

NCT05623020

NCT02424851

NCT06023043

NCT06022939

NCT04601701

NCT04601688

NCT04601675

NCT02186145

NCT06838715

NCT02412878

NCT02464176

NCT01908803

NCT01027650

NCT01228331

NCT05514990

NCT01188187

NCT04304144

NCT00411541

NCT06518551

NCT02226159

NCT00520767

NCT02540720

NCT07605416

NCT03979664

NCT06455748

NCT02384083

NCT03603119

NCT00411320

NCT02798835

NCT02989597

NCT01909856

NCT02464657

NCT03188172

NCT07605065

NCT01772381

NCT00410956

NCT02660762

NCT03808610

NCT02811978

NCT01028027

NCT04534322

NCT03007147

NCT05517499

NCT01499849

NCT00966693

NCT02519842

NCT01189292

NCT00410605

NCT03403517

NCT04883242

NCT05518383

NCT01042704

NCT05097768

NCT05519085

NCT03403712

NCT03603418

NCT00511706

NCT00410488

NCT02899052

NCT02799134

NCT02049476

NCT06785415

NCT02991339

NCT02575144

NCT01936532

NCT02185820

NCT00559481

NCT04284007

NCT01412879

NCT01225874

NCT04536662

NCT00109837

NCT06019728

NCT00564200

NCT02990338

NCT02071888

NCT05521087

NCT02473042

NCT02235584

NCT01028547

NCT04303065

NCT07429708

NCT03252457

NCT05522465

NCT03984097

NCT01910987

NCT04537026

NCT06203912

NCT03101137

NCT00973687

NCT00967057

NCT02661503

NCT01190930

NCT03098420

NCT05524038

NCT01403415

NCT01450007

NCT04037605

NCT02874742

NCT00003007

NCT00199186

NCT01661335

NCT04302324

NCT03723447

NCT02581046

NCT03261921

NCT01029054

NCT07428369

NCT07413055

NCT01660997

NCT06017167

NCT02389543

NCT06785090

NCT03618537

NCT02389517

NCT01660867

NCT04538820

NCT07576660

NCT01660802

NCT01660750

NCT03252600

NCT04892446

NCT03618264

NCT07413809

NCT03005522

NCT03005496

NCT00262925

NCT06016530

NCT06016465

NCT04892420

NCT04956302

NCT05527340

NCT04892264

NCT01042145

NCT01636947

NCT03618173

NCT02027272

NCT05096663

NCT04591600

NCT07150091

NCT00199108

NCT00636805

NCT06182774

NCT00408005

NCT04540133

NCT00263302

NCT07425678

NCT02164929

NCT05986318

NCT06511765

NCT06464991

NCT03617731

NCT04287660

NCT01659658

NCT04541147

NCT07150104

NCT06465992

NCT00003311

NCT07579234

NCT00263484

NCT03421041

NCT02272803

NCT07600151

NCT04891809

NCT01194453

NCT02027220

NCT04287855

NCT01194791

NCT01913730

NCT05530421

NCT05530811

NCT00096135

NCT00389701

NCT01222260

NCT00199095

NCT03605056

NCT01913990

NCT04205916

NCT01030601

NCT01030614

NCT05533281

NCT03004287

NCT03809442

NCT02346110

NCT05598255

NCT04891744

NCT01041378

NCT00236223

NCT04030988

NCT00972959

NCT05535036

NCT02576327

NCT01221103

NCT04588857

NCT02288078

NCT05988671

NCT03989414

NCT00390208

NCT06470100

NCT06470139

NCT03139591

NCT06470204

NCT06470334

NCT06508983

NCT02385110

NCT00861250

NCT00199082

NCT00968253

NCT04544683

NCT00562965

NCT05083169

NCT02471911

NCT06913374

NCT04545242

NCT04300556

NCT00003278

NCT00199069

NCT06783634

NCT02579863

NCT04891289

NCT02412657

NCT03668860

NCT04546126

NCT03507244

NCT03336073

NCT01198210

NCT00390793

NCT00639002

NCT07426081

NCT02024724

NCT02471820

NCT04588194

NCT07426042

NCT07581470

NCT07187167

NCT02542111

NCT02471651

NCT01639599

NCT03605719

NCT00391157

NCT00391170

NCT07187037

NCT00560352

NCT01639898

NCT00773838

NCT00560391

NCT06505369

NCT01640340

NCT04546399

NCT04027348

NCT05590923

NCT00104403

NCT03668639

NCT01774474

NCT04027322

NCT01410201

NCT06868667

NCT00871910

NCT02318433

NCT05991388

NCT00097981

NCT04547842

NCT03074773

NCT06189833

NCT03809780

NCT03993912

NCT00404066

NCT01217957

NCT02995746

NCT02576782

NCT07185373

NCT04025840

NCT02802163

NCT06186921

NCT00199056

NCT02807779

NCT03606577

NCT03995004

NCT05546060

NCT06187441

NCT02067078

NCT04890626

NCT07159620

NCT05546359

NCT02916771

NCT03100786

NCT06008795

NCT03995563

NCT04580121

NCT02873806

NCT03995628

NCT03418038

NCT00403806

NCT03615664

NCT02688530

NCT03140943

NCT00402766

NCT01217060

NCT02518113

NCT01917877

NCT04200651

NCT00098475

NCT04551131

NCT02541383

NCT02807454

NCT05549895

NCT02576977

NCT02918747

NCT07584200

NCT06188195

NCT03255473

NCT02467010

NCT03002259

NCT02916420

NCT00199017

NCT02897830

NCT00871013

NCT01451515

NCT05583617

NCT05552222

NCT05583214

NCT02649504

NCT00403065

NCT07182110

NCT04996160

NCT01919086

NCT03256045

NCT05552976

NCT07180953

NCT03416374

NCT07180940

NCT02387918

NCT01215344

NCT05553496

NCT05994183

NCT04889781

NCT07418671

NCT02756663

NCT03998982

NCT02288741

NCT03732703

NCT00103285

NCT06006624

NCT02427620

NCT06479317

NCT06918431

NCT00003217

NCT03411031

NCT00870103

NCT05581875

NCT01497093

NCT06496997

NCT00869973

NCT06868654

NCT00199004

NCT04201769

NCT03071822

NCT00402181

NCT01920737

NCT00401843

NCT02271698

NCT01920919

NCT01038388

NCT03506789

NCT00003213

NCT03256149

NCT00401804

NCT02386059

NCT00971685

NCT00869310

NCT01204164

NCT00869232

NCT00198991

NCT00222105

NCT03608501

NCT01033825

NCT01405924

NCT04555694

NCT05996406

NCT04001725

NCT04889547

NCT02289222

NCT03142893

NCT01212952

NCT00724568

NCT05558319

NCT01645930

NCT03412565

NCT03608839

NCT01652599

NCT01921790

NCT00401011

NCT04002037

NCT01408082

NCT00102609

NCT00723658

NCT00400946

NCT03000660

NCT06192979

NCT03609060

NCT05560399

NCT03506360

NCT05560542

NCT00235261

NCT04570631

NCT07588698

NCT05561387

NCT04570592

NCT00006455

NCT03000634

NCT05561725

NCT02578680

NCT00198978

NCT03143036

NCT00742404

NCT00742560

NCT00561743

NCT01647165

NCT05563155

NCT05573802

NCT04013386

NCT01211327

NCT07175623

NCT02803788

NCT02873273

NCT02412228

NCT02918331

NCT01926665

NCT02649790

NCT05564286

NCT03731832

NCT02069093

NCT00516009

NCT05090566

NCT05572515

NCT03729804

NCT02917941

NCT05998317

NCT00644228

NCT00515073

NCT01651039

NCT04561180

NCT02426723

NCT04561856

NCT02577783

NCT01923831

NCT02999633

NCT03731468

NCT03413800

NCT02468700

NCT00866307

NCT04005430

NCT00642954

NCT01036594

NCT02518750

NCT02426736

NCT07421817

NCT04566328

NCT04009109

NCT00101101

NCT06918002

NCT04008888

NCT04565301

NCT04563494

NCT03334487

NCT00772915

NCT06489808

NCT02578121

NCT06489626

NCT01208818

NCT04008043

NCT01208766

NCT01208662

NCT05567094

NCT03610893

Known as AR-1105 “PURPOSE: AR-1105 is a novel biodegradable sustained-release dexamethasone implant designed to deliver 6-month durability.” PMID 36542081 Oct 2022
Known as AR-1105-CF1 (dexamethasone intravitreal implant) AR-1105-CF1 (dexamethasone intravitreal implant)NCT03739593
Known as AR-1105-CF2 (dexamethasone intravitreal implant) AR-1105-CF2 (dexamethasone intravitreal implant)NCT03739593
Known as Corodex “The patients will receive Dexamethasone 8 mg (Corodex, Laboratorio Celsius, Montevideo, Uruguay) PO 1 hour before surgery (Almeida et al 2019)” NCT05924191
Known as Decadron “Anesthesia will be maintained with Sevoflurane, Magnesium, Lidocaine, Ketamine, Decadron, Ondansetron, and Ketorolac at a concentration range/dose(s) based on the clinical need...” NCT03367988
29

“Dexamethasone (Decadron®) will be given orally at a dose of 40 mg on days 1, 2, 3, 8, 15 and 22 during the first cycle and once a week on days 1, 8, 15, and 22 for each...” NCT00151203

“Dexamethasone (Decadron) caused minimal damage, while hydrocortisone (Solu-Cortef) and triamcinolone hexacetonide (Aristospan) caused widespread axonal and myelin degeneration.” PMID 7063571 Mar 1982

“QL block involves injection of 19 ml of 0.25% Bupivacaine and iml(4mg) of Decadron in a fascial place formed partly by the posterior surface of the quadratus lumborum muscle” NCT05480111

“The purpose of this study is to compare the safety and efficacy of XERECEPT® to dexamethasone (Decadron) a common treatment for symptoms of brain swelling (edema).” NCT00088166

“The medication used for the block are clonidine 100 mcg, Decadron PF 5mg and 0.25% bupivacaine 5 mL. This medication will be administered once during the block.” NCT04445337

“A Phase II Study of Dexamethasone (DECADRON®), Thalidomide (THALOMID®), and Lenalidomide (REVLIMID®) for Subjects With Relapsed or Refractory Multiple Myeloma” NCT00538824

“The names of the study drugs involved in this study are: * Teclistamab * Lenalidomide (also called Revlimid) * Dexamethasone (also called Decadron)” NCT05469893

“Steroids (such as Decadron or Dexamethasone) are medication used to reduce swelling around the tumour, and thus symptoms improve.” NCT00188864

“dexamethasone sodium phosphate (Decadron; 4 mg/mL; soluble). Again, this will be mixed with 1% lidocaine without epinephrine” NCT03641508

Decadron will be given at a dose of 0.2 mg/kg intraoperatively, followed by Decadron 4 mg. every 6 hours for 24 hours.” NCT01065961

“.075 mg IV Palonosetron (Aloxi) with 8mg IV Dexamethasone (Decadron) before surgery to see if this reduces PONV.” NCT00952133

“This was placed under ultrasound using 30 ml of 0.25% bupivacaine and 4 mg of Decadron.” NCT05257941

“dexamethasone (Decadron) 8 mg oral daily on days 2-4.” NCT05590923

“(volume per MD based on pt weight) + decadronNCT04180943

“Dexamethasone (Decadron) 8mg IM injection” NCT07109258

“Dexamethasone (DECADRON®)” NCT00538733

“Dexamethasone (Decadron)” NCT02793843

NCT00577993

NCT04766996

NCT02740127

NCT00450801

NCT00837200

NCT05965492

NCT03245671

NCT00429702

NCT00890656

NCT00413959

NCT02581839

NCT02577991

Known as Decadron (dexamethasone) Decadron (dexamethasone)NCT00783367
Known as Decadron for Dexamethasone Decadron for DexamethasoneNCT01270932
Known as Decadron PF “The medication used for the block are clonidine 100 mcg, Decadron PF 5mg and 0.25% bupivacaine 5 mL. This medication will be administered once during the block.” NCT04445337
Known as Decort “The pulp chamber was irrigated with 2 mL of a dexamethasone sodium phosphate solution at a concentration of 4 mg/mL (Decort®, DEVA Holding, Türkiye).” NCT07233577
Known as DECTANCYL “B :dexamethasone (DECTANCYL)” NCT02552251
Known as Desamethasone “* Desamethasone 40 mg days 1-4” NCT02371161
Known as DEX “The non-inferiority of dexamethasone (DEX) on day 1, with or without low-dose DEX on days 2 and 3, combined with oral NEPA (netupitant/palonosetron), compared with the...” PMID 35999527 Aug 2022
46

“This study will investigate the efficacy and safety of OZURDEX® (dexamethasone intravitreal implants; DEX, Allergan, Inc. Irvine, CA) as monotherapy for the treatment of...” NCT05101928

“The aim of this study is to evaluate the effectiveness of submucosal 8 mg (2 mL) dexamethasone (DEX) on postoperative pain, swelling, chewing efficiency, trismus, healing, and...” PMID 39627624 Dec 2024

“D (Dexamethasone) group: (n=100) each patient received a placebo tablet identical to paracetamol tablet orally with sips of water and Dex 8 mg ampoule diluted in 100 ml 0.9% NS...” NCT03679065

“PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR...” NCT00002716

“OBJECTIVE: To compare the efficacy of a single dose of oral dexamethasone (Dex) versus 5 days of twice-daily prednisolone (Pred) in the management of mild to moderate asthma...” PMID 17198210 Dec 2006

“The combination of dexamethasone (DEX), ondansetron (OND) and droperidol (DRO) is efficacious in preventing postoperative nausea and vomiting in adults, but has not been well...” PMID 28505233 Jun 2017

“Guidelines recommend the combination of a neurokinin-1 receptor antagonist (NK1RA), 5-hydroxytryptamine-3 RA (5-HT3RA), and dexamethasone (DEX) for CINV prophylaxis in...” PMID 28285236 Mar 2017

“We therefore conducted a phase I/II study to establish the safety and preliminary efficacy of IXA with pomalidomide (POM) and dexamethasone (DEX) in lenalidomide (LEN)/PI-refractory MM.” PMID 34559902 Oct 2021

“The study will test a new combination of 3 drugs: Isatuximab (Isa), Iberdomide (Iber) and Dexamethasone (Dex), in patients who have intermediate or high risk smouldering myeloma.” NCT06762769

“The patients were allocated equally into 2 groups by block randomization to receive either loteprednol etabonate (Lot) or dexamethasone (Dex) for 1 month after the surgery.” PMID 25555173 Jan 2015

“The marked activity of thalidomide (thal) and dexamethasone (dex) in relapsed and refractory multiple myeloma (MM) provided the basis for this phase 2 clinical study” NCT01341262

“This study is a phase 1/2 study to assess safety and hematologic response rate of Ixazomib (MLN) in combination with Cyclophosphamide (CTX) and Dexamethasone (DEX).” NCT03236792

“Intrathyroid injection of dexamethasone (DEX) has been used to treat Graves' disease (GD); however, the mechanism of this treatment remains poorly understood.” PMID 22219499 Jan 2012

“The synthetic glucocorticoid dexamethasone (Dex) is a potent cortisol surrogate and glucocorticoid receptor (GR) agonist that resists 11βHSD2 inactivation.” NCT01769820

“received either four weekly glucocorticoid (dexamethasone [DEX]) or placebo administrations paired with a 45-second trauma memory reactivation task.” PMID 29466111 2017

“perineural dexamethasone (DEX) versus dexmedetomidine (DEM) when used as adjuvants to ropivacaine in pediatric popliteal sciatic nerve blocks” PMID 41043950 Oct 2025

“preemptive single-dose etoricoxib, preemptive single-dose dexamethasone, and no premedication in impacted mandibular third molar surgery” NCT05791721

“To evaluate the ability to induce serum folate receptor (FR) with dexamethasone (Dex) and valproic acid (VPA) treatment” NCT02520115

“high-dose systemic methotrexate (MTX) and dexamethasone (DEX) combined with zidovudine (AZT) and brain irradiation” NCT00000723

Dexamethasone (Dex): 20mg tablets taken during both treatment phase 1 (21 days \& treatment phase 2 (42 days)” NCT02290431

“Lenalidomide (Len) and Dexamethasone (Dex) for 6 months followed by three donor lymphocyte infusions (DLIs)” NCT03413800

“adjuvant dexamethasone (dex) and thalidomide (thal) in an attempt to reduce TRM and improve response rates.” NCT01527032

Dex was presented as dexamethasone sulphate ampoules 8mg in 2ml. (Medical Union Pharmaceutical, Egypt MUP)” NCT03250494

“extended dexamethasone (Dex) treatment induces irreversible cell cycle blockade and a senescence phenotype” NCT04037462

“Daratumumab (DARA) in combination with pomalidomide (POM) and low-dose dexamethasone (dex) (DPd)” NCT03651128

“a dexamethasone intracanalicular insert (DEX) for treatment of allergic conjunctivitis (AC).” PMID 39328900 Sep 2024

“hepatic arterial floxuridine (FUDR) and dexamethasone (Dex) given via an implanted pump” NCT00059930

“Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate (B-DEX-MPA)” NCT05279092

“with hepatic arterial infusion (HAI) of floxuridine (FUDR) and dexamethasone (Dex)” PMID 19233901 Feb 2009

“Treatments including physical activity (PA) or dexamethasone (Dex) improve CRF;” PMID 34965510 Dec 2021

Dexamethasone (DEX): 10 mg/m2 EV, IM or PO days 1-2, 8-9 days 15-16, 22-23. .” NCT01376427

“* Dexamethasone (DEX): 10 mg/m2 EV, IM or PO days 1-2, 8-9 days 15-16, 22-23.” NCT01358201

“HR20013 plus dexamethasone (DEX) versus fosaprepitant (FAPR) plus PALO + DEX” PMID 39621965 Dec 2024

“All subjects will receive TJ202 and dexamethasone (DEX) in the study.” NCT03860038

“preservative-free dexamethasone (DEX), diclofenac (DICLO) eye drops” PMID 36602718 Jan 2023

“The most striking results were seen with dexamethasone (Dex).” PMID 26707935 Dec 2015

“the use of 3-day dexamethasone (DEX) is often recommended” PMID 32735029 Aug 2020

Dexamethasone (DEX) is the most frequently used steroid.” NCT04266977

DEX (dexamethasone) 8 mg/m2 PO daily (tid) x 7 days” NCT00187005

Dex 6 mg/m2 PO; in 3 divided doses daily x 7” NCT00187057

“floxuridine (FUDR)/dexamethasone (Dex)” PMID 21677464 Jun 2011

dexamethasone sodium phosphate (DEX)” NCT03977454

dexamethasone (Dex) orally” NCT03234972

dexamethasone (Dex)” NCT00030069

Dexamethasone (DEX)” NCT01862315

NCT03977454

Known as Dex 21-P ClinicalTrials.gov intervention name — accepted as the source's own label NCT01171807
Known as DEX implant “Dexamethasone intravitreal implant (DEX implant; OZURDEX, Allergan, Inc., Irvine, CA)” NCT01581151
Known as DEX, dexamethasone DEX, dexamethasoneNCT03629210
Known as DEX-I “Dexamethasone Intravitreal Implant (DEX-I, 0.7 mg)” NCT07438119
Known as DEXA “This paper describes the rationale and detailed protocol for a randomised controlled trial evaluating the efficacy of dexamethasone (DEXA) in reducing PES after PAE.” PMID 34725072 Nov 2021
2

“Patients receive dexamethasone (DEXA) on days 8-28.” NCT00613457

“Patients receive dexamethasone (DEXA) on days 8-28” NCT00430118

Known as DexaEDO DexaEDO (dexamethasone) eyedrops without preservatives are applied additionally.” NCT01228149
Known as Dexametasone “Drug: DexametasoneNCT07068048
3

NCT02036489

NCT01562977

NCT02238340

Known as Dexamethason dexamethason (d 1, 2, 8, 9, 15, 16, 22, 23, 20mg, oral/intravenous injection)” NCT04612582
1

NCT00619086

Known as Dexamethasone (0.4mg) Insert Dexamethasone (0.4mg) InsertNCT05116345
Known as Dexamethasone (Caspian Tamin Pharmaceutical Co, Rasht, Iran) Dexamethasone (Caspian Tamin Pharmaceutical Co, Rasht, Iran)NCT03531970
Known as Dexamethasone (D) Dexamethasone (D)NCT01858922
Known as Dexamethasone (Decadron) “Dexamethasone (Decadron®)” NCT02128230
2

Dexamethasone (Decadron)NCT02724033

Dexamethasone (Decadron)NCT00250926